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The interest in inserting automatic elements to support diagnostics,
within the healthcare system, is one of the main actors that in recent
years has driven the research and development of Artificial Intelligence
(AI) applications. Technological advances, the refinement of algorithms,
the computational resources increase and the extraordinary capacity of
prediction, have contributed to the proliferation of AI research. Major
advances have been driven by the spread of Deep Learning (DL). The
healthcare institutions are still not ready to integrate AI applications in
their diagnostic workflows. In spite of the advances in the research fields,
the publicly available datasets are often unrepresentative of real noisy
data. This difficulty lies in the inherent complexity of using data from
patient screening, whose sharing and precise annotation for automatic
tools is not part of the medical routine, yet. As a consequence,
collaboration between institutions is not guaranteed and data are
not easily shared, and therefore AI solutions exhibit little diagnostic
generalization. The European Union stands at this challenge funding
projects aiming to contribute filling this gap, such as DeepHealth.
In this thesis we investigate two challenging problems related to the
diagnostic prediction from visual reports; in particular, we highlight the
complexity of data management and pre-processing, and how DL can
support physicians in their diagnostic process. In the beginning, we
will address the generalization problem from a methodological point of
view. We will present our useful tool for generalization of DL models,
called PostSynaptic Potential (PSP), based on a training regularization
approach. Specifically to the medical image processing domain, we
will first tackle a histo-pathological tissue classification, in particular
colorectal polyps and their degree of dysplasia, and we show that DL
can achieve comparable accuracy as human pathologists. Then, we
switch from image classification to an image generation task. In this
ii
scenario, we will discuss the generation of brain perfusion maps from
patients with ischemia. Perfusion maps are the result of patient exams
that shows vessel occlusion in the brain. We take into account brain
computed tomography scans in order to predict three types of perfusion
map. With the perspective of making these analyses effective tools for
diagnostic pipelines, an analysis of the solutions is proposed, based on
the AI development tools proposed by DeepHealth.
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The landscape of healthcare and biomedical research is chang-
ing rapidly through involvement of artificial intelligence into
their processes. Artificial Intelligence (AI) has recently re-
ceived new scientific and public attention, with technology
companies and researchers releasing new breakthroughs and
technologies at a breakneck pace. For such reasons, AI tech-
nologies applications start to become increasingly prevalent
also in business and society other than in healthcare and in
research. Many aspects of patient care, pharmaceutical and
medical processes can be heavily influenced and transformed
by the potential of these technologies. Several studies have
already shown that artificial intelligence can perform basic
healthcare tasks, such as disease diagnosis, at least as well as
humans. As an example, researchers from Google Inc., by col-
laborating with medical institutions, demonstrate how an AI
system can be trained on a huge amount of images and how
it can reach levels of sensitivity and specificity performance,
comparable to clinician’s ones, in diagnosing relative diabetic
retinopathy and also can detect associations, previously unrec-
ognized, between the images [32]. AI is essentially a branch of
computer science that aims to understand and build intelligent
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beings that are implemented as software. The first usage of an
AI system in the medical field can be found at Dartmouth
Conference in 1956 [70]. In the early 2000’s, many practical
limitations were overcome by new AI paradigms. Since 2012,
the rapid and promising development of image classifiers has
deeply contributed to the rise of artificial intelligence contri-
bution in the last years. Although there have been significant
advances and progress in recent decades, AI has been plagued
by a constant question that is far to be resolved: “What the
"true AI" is?”. A "true AI", or also "strong AI", is can be
defined as computer programs that can experience sentience,
self-awareness and consciousness [73]. By contrast, "weak AI"
is limited to the use of software accomplish specific problem
solving tasks [25]. A well-known feature of AI research is that,
once a certain performance goal is achieved in resolving a cer-
tain task, future progress needs to be measured by different
criteria. For example, AI technology achievements from the
1970s to the 1990s, such as automatic interpretation of elec-
trocardiograms, are probably not examples of true AI, despite
once considered medical breakthroughs and now considered
useful. Currently, algorithms are already better than radiolo-
gists at detecting malignancies and creating cohorts for high-
risk clinical trials. More recently, the application of medical
imaging systems has pushed the boundaries of AI into areas
that used to be the domain of medical specialists. The AI ap-
plication limits are far to be conquered and they continue to
expand, also into several other medicine areas, including clini-
cal practice, translational medical research, and basic biomed-
ical research. However, artificial intelligence can be considered
many years away from replacing humans in a wide range of
medical processes. Several reviews reports the AI influence in
healthcare, can be referred in order to take inspiration and
information [98, 21] and to build our own perspective for the
near future.
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1.1.1 AI history in medicine
Researchers have developed and presented systems for clinical
decision support since the mid-twentieth century. Intuitively,
the medicine support was the most studied application for Ar-
tificial Intelligence from the dawn of his birth [98]. Rule-based
expert systems and approaches, based on “if-then” rules, are
an AI technology that became mainstream from late 1970s and
and have been widely used commercially since then. In health-
care, they have been widely used for clinical decision support
in recent decades and continue to be used today: the common
usage is to interpret electronic health records (EHRs), then
they provide support for disease diagnosis, appropriate patient
treatments selection, clinical conclusions interpretations, and
diagnostic hypotheses generation. Nowadays EHR vendors of-
fer their own sets of rules for their systems. Expert systems
require experts or knowledge engineers to create rule sets for
specific knowledge areas. That makes rule-based systems ex-
pensive and vulnerable because they require explicit decision
rules and, like textbooks, must be updated and validated by
expert humans for each specific competence field. Moreover,
it has a non-trivial issue: the rule systems increase in com-
plexity by trying combine both deterministic and probabilistic
elements in their decision processes. However, the cardinality
of these rules increases usually more than a thousand and the
rules begin to conflict with each other and raise the probability
to create failure points. In addition, when changes occur in the
knowledge domain, changing the rules is time consuming and
difficult also for experts in their domain. These reasons are the
cause of the slow replacement of expert systems in healthcare
by more comprehensive approaches based on data collection
and machine learning algorithms [98].
During the last decade, a massive media interest raised
around IBM Watson [68] and its focus on precision medicine,
specifically cancer diagnosis and treatment. IBM Watson uses
a combination of machine learning and machine speech pro-
cessing capabilities. However, IBM Watson is designed to be
a set of "cognitive services", delivered through application pro-
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gramming interfaces (APIs), and not a standalone product. Its
services include speech and language data analysis, vision and
machine learning programs. The initial enthusiasm for using
the technology is diminished as the clients realized the IBM
Watson’s training complexity: in cancer-specific treatments,
integrating it into treatment processes and systems seams al-
most infeasible [68]. While IBM Watson’s APIs are techni-
cally superior, most agree that the effort to cure cancer is too
ambitious. IBM Watson left room for others "open source"
AI builders solutions, such as Google’s TensorFlow and Face-
book’s PyTorch [98].
In the first generation of AI systems, experts organized
medical knowledge and developed correct decision rules
to make automatic inferences, but the recent AI research
starts to develop machine learning (ML) techniques, useful
to explore complex task interactions, in order to identify
patterns in data [24].
As we said before, the ML research is focused today in
building artificial neural networks and in developing deep
learning algorithms for deep multilayer ANN. The community
is hardly working to build neural networks for biological and
medical applications. However, deep learning algorithms
are very “data-hungry”. In most of the cases, data have to
come labeled and pre-processed in order to achieve useful
performances for real applications. Large datasets of medical
cases have become available only in recent times, thanks to
the demand of large scale studies, data-collection platforms
and financial incentives. EHR systems, mentioned before, will
not only accelerate the collection of large amounts of clinical
data, but also enable more rational use of AI systems into
the clinical workflow [98]. This is only a first step, but it is
often not enough to guarantee a real data collection sufficient
to train ANN-based AI algorithms for many clinical tasks. In
addition to the difficulty of data collection, there is also the
difficulty of generalizing the use of data-based AI algorithms.
By generalization of an AI algorithm, we mean the ability
to predict with respect to unseen data. Consequently, for
training a machine learning algorithm, the collected data
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must be divided into at least two different sets, called
“training set” and “test set”, respectively. Consequently, the
generalization capacity refers to the goodness of predictions
over the “test set”. Different institutions use different data
acquisition techniques and machines for the same types of
patient screening. Indeed, we can think at data from external
medical institutions as additional “test sets” for AI algorithms.
This heterogeneity is a major challenge for the reusability of
the same ANN models across multiple medical institutions.
We will treat the generalization problem in more detail in
Sec. 3.1.
Traditionally, physicians have collected medical infor-
mation about patients, performed clinical assessments, and
recorded diagnoses and treatments in the medical record.
After decision support systems have entered the market, with
which it is possible to collect medically relevant information
and make recommendations to physicians. Automatic decision
support systems can be integrated into clinical workflows in a
variety of ways. For example, decision support systems can
proactively collect information about patients and electronic
health records, make recommendations to physicians, and
store the results of the system in EHR systems. In many
proposed fully automated clinical systems, autonomous tools
collect patient data, make decisions, and export results to
the patient, but this kind of integration is far from being
a consistent, usable and reliable real clinical workflow [98].
The explosive growth of healthcare artificial intelligence in
recent years is due to the collection of large annotated clinical
datasets, the development of machine learning techniques,
open-source training packages, and affordable and rapidly
increasing computing power. This can lead to a valuable
transformation in medical practice in the near future, as
AI systems can perform many expert-level diagnostic tasks
and predict patient prognosis better than physicians[100].
As machine learning models become more sophisticated, AI
could be involved in medical practice and redefine the role of
physicians in the process [41].
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1.1.2 Future challenges in Healthcare
We believe that artificial intelligence will play a key role in
the medical service proposal in the near future. In the form
of machine learning, it is a key component in enabling the
development of precision medicine, which needs to constantly
improve provided care. Hinton, as one of the pioneers of neural
networks, and many AI researchers predicts dramatic changes
in medical practice [60]. Since the early stages, AI is expected
to play a role in this field, although diagnosing and suggesting
treatments will be difficult. By reducing human error and
physician fatigue in routine clinical tasks, artificial intelligence
has the potential to drastically improve the quality of health
care. However, it will not necessarily reduce the expert amount
of work: as clinical guidelines recommend, high-risk patients
need more frequent testing. Until now, most medical decisions
have been made by humans, but the use of intelligent machines
to make and support decisions raises side implications that are
not strictly medical.
Ethical implications
This has led to a number of ethical issues regarding the use
of AI in healthcare. Perhaps the most difficult problem to
solve with current technology is transparency. Many artifi-
cial intelligence algorithms, especially deep learning algorithms
used for image analysis, are almost impossible to explain or ac-
count for. If a patient is told they have been diagnosed with
cancer because of a certain image, they will want to know
why. Deep learning algorithms may be impossible to explain,
even to doctors who have a general understanding of how they
work [21]. Artificial intelligence systems are not error free,
and they could make mistakes when diagnosing and treating
patients, and it can be difficult to place the blame on them. It
is also possible that patients may receive medical information
from AI systems, which has, from the patient’s point of view, a
different psychological impact than consulting an experienced
physician. Machine learning systems in health care can also
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be affected by algorithmic bias, predicting a higher probabil-
ity of illness based on gender or race, when in fact there is no
causal relationship. As AI is used in healthcare, it will face
many ethical, medical, professional and technological changes.
It is important that healthcare organizations and government
and regulatory agencies have governance structures in place to
monitor key issues, respond responsibly, and mitigate negative
impacts [21].
Physician workflow implications
Successful implementation of AI for routine clinical tasks will
allow physicians to focus their time on more complex tasks and
devote more time to patients [98]. It also seems increasingly
clear that AI systems are not meant to replace human doc-
tors on a large scale, but to complement patient care. Over
time, doctors may shift their approach to the job in favor of
assignments that rely on mostly human skills such as empathy,
persuasion, and general thinking. Replacing routine tasks with
AI for some health care providers may result in re-design the
healthcare workforce needs.However, there is little empirical
evidence of such an impact on clinical practice. Current AI
applications will not reach their full potential unless they are
integrated into clinical workflows [9, 53]. Machine learning-
based models pose a unique challenge for regulators because
models evolve rapidly as data and user feedback are collected.
Evaluating and updating adopted models is not trivial. For
example, a new model may be better on average but perform
poorly on a subset of patients. As data collection becomes
a more common practice, we need a consensus framework to
guide health-related data sharing. As automated AI becomes
more prevalent in certain clinical tasks, the skills needed to di-
agnose, treat, support, and assist will need to be updated, and
the roles of healthcare professionals will continue to evolve as
various AI modules are incorporated into standard treatments.
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Regulatory implications
For artificial intelligence systems to be widely adopted, they
will require regulatory approval, integration into EHR sys-
tems, standardization so that similar products work in the
same way, guidance to clinicians, payment by public or pri-
vate payers, and updates over time in the field. These chal-
lenges will be overcome over time, but that will take much
longer than the maturation of the technology itself. To ad-
dress these challenges, AI researchers and clinicians will need
to work together to prioritize and develop applications that
address critical clinical needs. Hospital administrators must
assess and mitigate disruptions to clinical workflows when im-
plementing new AI applications. Organizations need to define
an appropriate framework for prospective clinical trials to eval-
uate the performance of AI systems in the clinical environment.
Insurers need to assess the value of AI systems in healthcare
and potentially change their reimbursement policies to reduce
healthcare costs and improve quality. Interdisciplinary and
cross-sectoral collaboration is needed to facilitate the develop-
ment and deployment of AI applications in healthcare. This is
one of the most powerful and influential technologies in society
and will require sustained attention and thoughtful policies for
years to come.
1.2 Thesis goals and contributions
Healthcare is different from other areas where machine learning
can be applied. While progress has been made in other data
driven fields, what complicates medicine is not the volume of
collectible data itself, but the problem arises in extracting use-
ful insights from both complex and high dimensional data. It
is these kinds of problems that make medicine the most in-
teresting field for those who are really interested in pushing
forward the AI limits. This means that we can solve real prob-
lems that are relevant to society and can affect all of us. In
this thesis we want to address different issues concerning the
sphere of biomedical image analysis, a perfect example of bi-
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ased and high dimensional data. In particular, the focus will
be on the study of Deep Learning AI techniques applicability
to solve these delicate tasks. In this thesis, we will show mul-
tiple types of contributions, each one linked to the main AI
application support to healthcare.
Methodological contribution
First, a careful analysis of generalization guarantees is pro-
posed. In this context, we will see how some innovative tech-
niques, such as “regularizations”, can mitigate the undesir-
able effects of biased data or poor data collections. We pro-
pose, as DL “regularization” technique, Post Synaptic Poten-
tial (PSP) [6], detailed in Sec. 3.2, and how it can be ap-
plied to improve the overall generalization of Deep Learning
applications on different datasets. This methodological con-
tribution to the generalization support techniques pool can be
extended beyond the experimental domain and applied to con-
texts such as the medical domain. Real-world problems, as in
healthcare, are more complex to handle rather than research
tasks on well-known dataset. Solutions to this tasks have to
be tuned and rethought in order to fit the complexity of the
data and the retrieved insights must be relevant to the do-
main expert. Therefore, methodologies and studies on multi
resolution classification in biomedical image analysis trough
Convolutional Neural Network (CNN): Histopathological col-
orectal tissue analysis and dysplasia grade prediction for polyp
classification are will be further discussed, by also proposing
a novel class inference method, above our analysis results [5],
based on stacked multi resolution classifiers [1].
Experimental contribution
We will see how AI can be intended to solve these problems
and we look at these solutions in the context of EU Deep-
Health project. DeepHealth provides us the support to create
large-size medical image datasets and propose its own Deep
Learning framework ecosystem to face these challenges. In an
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era in which large, foreign and private technological companies
can expand the use of their software resources into very sen-
sitive domains, such as healthcare, a common reference tool
becomes necessary for the evaluation of AI-based solutions.
As experimental contribution to the project, we use the Deep-
Health Toolkit to reproduce a specific medical image analysis
task based on computed tomography. The application per-
forms an automatic processing for perfusion map generation
in patients with ischemic strokes and cerebral vessel occlu-
sions [4]. Moreover, the experimental contribution continues
with an overview of technical metrics comparison will be pro-
vided in order to find strong and weak points in the current
European toolkit for deep learning development. This com-
parison will take into account the Computer vision and the
Deep Learning libraries provided in the European toolkit, at
the current release stage, and the most popular DL library for
research purpose, PyTorch.
Dataset contribution
The dataset collection in the healthcare context is the key
factor to train AI models and to develop AI applications able
to generalize well across institutes data. The data itself is
also challenging to collect due to many factors. For example,
the raw data samples usually have very high resolution and
the sample distribution follows the disease appearance in the
patients. For both medical cases, histopathological colorectal
polyps classification and brain perfusion maps generation, we
share to the community the datasets we collect. As a dataset
contribution to the healthcare research community, we created
UniToPatho [2] and UniToBrain [3].
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Figure 1.1: The logo of DeepHealth
1.3 European Union in
Healthcare and AI:
DeepHealth Project
Part of the research we are going to discuss in this thesis
have contributed to the development and to the evaluation of
the DeepHealth project products. Deep-Learning and HPC
to Boost Biomedical Applications for Health (DeepHealth)
project [22] is funded by the European Community Horizon
2020 research and innovation program under the topic
ICT-11-2018-2019 HPC and Big Data enabled Large-scale
Test-beds and Applications. Kicked-off in mid January 2019,
DeepHealth is a 3-year project and is expected to conclude
its work in June 2022. The aim of DeepHealth is to offer a
community available unified framework completely adapted
to exploit underlying heterogeneous and parallel High-
Performance Computing (HPC) and Big Data architectures.
The DeepHealth framework is assembled with state-of-the-art
techniques in Deep Learning (DL) and Computer Vision (CV).
In particular, the project will combine HPC infrastructures
with Deep Learning and Artificial Intelligence (AI) state-of-
the-art developing tools to support and integrate biomedical
applications that require the analysis of large, complex and
biased biomedical datasets and thus, new and more efficient
ways of automated diagnosis, monitoring and treatment of
severe diseases. Healthcare is one of the driving key sectors
of the global economy, especially in Europe: the level of
current healthcare expenditure was over EUR 1000 billion in
2018 [28]. Any improvement in healthcare systems has a high
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impact on the welfare of the society. The use of technology
in health care is undoubtedly an important path to improve
its efficiency: both individuals and government budgets can
benefit from the effectiveness of the use of technology. Today,
European public health systems generate large data sets,
mostly biomedical images and other general biomedical data,
since most medical examinations use image-based processes.
These datasets are constantly growing and represent a large
untapped knowledge base because much of their value comes
from interpretations by medical experts, and this process
is usually time-consuming and manual. In addition, global
knowledge sharing between institutions is complex due to
different or unclassified information systems, as well as data
confidentiality restrictions and limits.
In the context of automation and acceleration of data and
process analysis in healthcare, scientific discovery and innova-
tion in healthcare is expected to move rapidly toward the so-
called “fourth science paradigm”, which is based on the integra-
tion of traditionally unrelated and heterogeneous environments
for high-performance computing and big data analysis. Under
this paradigm, the DeepHealth project will provide HPC com-
puting power at the service of biomedical applications; and
apply Deep Learning (DL) techniques on large and complex
biomedical datasets to support new and more efficient ways of
diagnosis, monitoring and treatment of diseases.
The aim of DeepHealth is to offer a unified framework com-
pletely adapted to exploit underlaying heterogeneous HPC and
Big Data architectures; and assembled with state-of-the-art
techniques in Deep Learning and Computer Vision. In partic-
ular, DeepHealth framework is envisioned to tackle real needs
of the health sector and facilitate the daily work of medical per-
sonnel and the expert users in terms of image processing and
the use and training of predictive models without the need of
combining numerous tools. To this end, the project will com-
bine High-Performance Computing (HPC) infrastructures with
Deep Learning (DL) and Artificial Intelligence (AI) techniques
to support biomedical applications that require the analysis of
large and complex biomedical datasets and thus, new and more
12
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efficient ways of diagnosis, monitoring and treatment of dis-
eases. Moreover, two new libraries, the European Distributed
Deep Learning Library (EDDLL) and the European Computer
Vision Library (ECVL), will be developed and incorporated in
theDeepHealth framework for manipulating and processing the
images in a more efficient way and thus, for increasing the pro-
ductivity of professionals working on biomedical images. As a
result, improved diagnostics will greatly improve the quality
of health care for society, making health care systems more
efficient and affordable for all.
Great expectations come from the massive usage of inno-
vation technologies in the heath care sector. The exploita-
tion of jointly collected health big data [18] and the power-
ful promises in Artificial Intelligence (AI)/Machine Learning
(ML) [17] can lead to a significant metamorphosis in diagnosis
process. The DeepHealth project aims at contributing to such
epochal change exploiting one of the “biggest big data”, i.e.
biomedical multidimensional images and state of the art AI
based on Deep Learning (DL) methods [47, 21, 93, 12]. DL is
obtaining astonishing results in many sectors, with healthcare
making no exception. The DL approach is based on training
deep and complex Neural Networks – more specifically, Con-
volutional Neural Networks (CNNs) which are well suited to
images. The training of neural networks from large datasets
of images requires significant amounts of computing resources
and this is why one of the main goals of DeepHealth is to
combine and optimize the computing power of HPC systems
with Big Data software for efficiently training DL algorithms.
Moreover, in order to develop industry-ready solutions, it is of
utmost importance to consider the flexibility, scalability and
efficiency of these solutions. Within this context, DeepHealth
aims at providing not only the maximum raw performance, but
also at designing a framework capable of automatically select-






2.1 Deep Learning overview
In its early days, artificial intelligence (AI) focused on rule-
based systems that made predictions by using predefined sets
of rules. These rules have to be provided and verified by ex-
perts. However, these systems were fragile and relied on ex-
pert advice, which eventually led to their obsolescence. As the
size and volume of data increased, these approaches were re-
placed by a more data-driven approach, called machine learn-
ing (ML). Machine learning is a set of algorithms and processes
that allow machines to discover and understand patterns in
data and take advantage of that structure to reason and make
inference about specific tasks. In order to understand these un-
known patterns, many approaches are possible. As we know,
one of the most notable advances in AI in recent years has
been called Deep Learning. Machine learning techniques, and
the subsequent development of AI applications, aim to detect
previously unrecognized patterns in data. These pattern dis-
coveries are made without having to define, for each specific
task, manually crafted decision rules by domain experts, by
taking account complex similarities between inputs. Unravel-
ling data patterns directly from the sources is an advantage
in terms of domain experts effort and working time. Indeed,
14
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machine learning has become the mainstay of AI tools. Nat-
ural language translation, pattern recognition and gaming are
some of the tasks where deep learning models can match or
exceed human performance. The recent success of AI has been
also driven by the use of now available large data sets. In
the past, collecting huge amounts of data samples in a given
domain was prohibitive in terms of human resources and phys-
ical resources, like storage or bandwidth to share the dataset.
Nowadays, many of the technological limits have become less
constraining, therefore the data collection effort is mitigated.
These large sources of data are needed in order to train multi-
level Artificial Neural Networks (ANN), also calledDeep neural
networks. An important factor of the rising success of Deep
Learning (DL) is both the availability of real-world data sets
and the constantly growing hardware capability to handle their
processing. What is the relationship between machine learning
and Deep Learning? How does deep learning fit into the field
and what are the main applications and challenges? There is
a misconception that deep learning is a competing technology
in the field of machine learning. Deep Learning is a sub-field
of machine learning. Deep learning is a machine learning tech-
nique that is characterized by its computational depth. With
improved computer performance in terms of memory, storage
end GPUs capability, and the availability of large data sets,
deep learning algorithms are able to learn patterns that are
hidden in the data itself, and thereby make predictions. Deep
learning can be thought of as a branch of ML that learns from
huge amounts of data and takes advantage of a large number of
computing units at the same time to output the designed pre-
dictions. To create a learning system that works like a human,
the architecture of deep learning draws inspiration from the
structure of the human brain. Thus, many of the fundamental
concepts used in deep learning are familiar to neuroscience.
Just as neurons are the basic building blocks of the brain, the
architecture of deep learning has its own “neuron” as a mini-
mal computational unit. The first ANN composed by a single
neuron was called perceptron and its concept was introduced
in 1958 by the psychologist Frank Rosenblatt. It is with this
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artificial neuron that the magic of deep learning begins. This
basic computational unit weights its input and produces a sin-
gle output signal, much like the neurons in the human brain
transmit electrical impulses that cross all the human nervous
system. The artificial neuron is designed to filter, or catch,
some elementary pattern of the data: by stacking multiple
neuron layers, we have a structure that is sensitive to much
more complex hierarchical patterns, and, at the end, capable
of understanding a representation also in the most complex
real-world data sets. A layer can be seen as a large set of
smaller computational units that learn to identify repeated in-
put values. Each perceptron layer is sensible for interpreting a
particular pattern in the data. Because the perceptron design
and these perceptron networks remind the way neurons form
networks in an animal brain, their architecture is called a neu-
ral network (NN or artificial neural network (ANN). NN are
so become the natural model for deep learning because of their
power and scalability. We are going to observe and analyze in
details the neuron/perceptron structure later in the discussion,
that is represented in Fig. 3.2 in Sec. 3.2.2.
2.2 Deep Learning applied to images
The basic architecture of a deep neural network consists of an
input layer, an output layer, and several hidden layers in be-
tween. The feedforward neural network is the simplest model,
which consist in one single hidden layer mades of perceptrons,
that forward the inputs in the input layer to the output layer.
From there, the research in the AI field gives us a multitude
of more complex models in order to fit each sort of task and
manage multiple types of inputs. As proof, the success of Deep
Learning was raised by the models capability to solve complex
tasks on processing images. For example, Autoencoders are
used for dimension reduction or provide useful additional out-
puts, like reconstructing images. Autoencoder variants, like
U-Net, are designed to produce segmentation/semantic maps.
Generative Adversarial Networks (GAN) can even generate
16
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Figure 2.1: Visual representation of feedforward neural net-
work with an hidden layer made of 4 perceptrons. Each percep-
tron receive as inputs all the outputs signals from the previous
layer.
completely new images with the same characteristic of the in-
put ones. Recurrent neural networks are useful for processing
time-series data. Deep residual neural networks, introduced as
ResNet, are used for image classification and they are based on
traditional deep feed-forward neural networks to avoid saturat-
ing model performance by missing connections [35]. Modern
ANNs have millions of parameters, and training them requires
enormous computational resources. Fortunately, most recent
advances in computer and processor design have provided the
necessary processing power for deep learning. For example,
modern graphics processing units (GPUs) could perform over
a trillion floating point operations per second, so they can pro-
cess millions of medical images per day at relatively low cost.
Some modern neural networks can reach more than 100 layers
in depth. Neural networks with multiple layers can model com-
plex relationships between inputs and outputs, but may require
more data, computation time, or complex architectural design
to achieve optimal performance. Various layers, mathematical
operations on neurons, and normalization methods have been
developed to achieve this results. For example, recurrent lay-
ers use circular connections to model temporal events, while
convolutional layers are useful for extracting spatial or tem-
poral connections. Deep Learning relies on processing power,
17
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large data sets, and “convolutional” neural networks (CNN) to
handle tasks in the image domain. CNNs use convolutional
types of layers to transform and and compress local groups of
pixels in an image to extract some high-level features. Convo-
lutional layers introduction into ANNs have become a standard
technique for extracting local spatial correlations on multidi-
mensional inputs such as images. Before CNNs, image fea-
tures had to be identified and extracted by hand-crafted or
rule-based models, and the performance of machine learning
models depended on the quality of those features. A major
improvement of CNNs is that they work with the original im-
age and can learn useful features from the training set, sim-
plifying the learning process and facilitating the recognition of
image models. This is critical to the success of deep learning
in image analysis and has contributed to the revolution that
has emerged also in medical imaging.
Depending on the type of task the AI wants to solve, the
main machine learning algorithms can be broadly classified as
“supervised” and “unsupervised”.
• Supervised DL algorithms are possible by collecting a
large number of “training” instances containing input
data (e.g. in medical domain they can be tissue images)
and desired output labels (e.g. a carcinoma diagnosis
for such tissue). Supervised ML methods require both
data and the prediction (also called label, class or ground
truth) that the model is supposed to infer from the data
itself. The model is trained to produce the correct pre-
diction for a given data instance, by learning the rele-
vant features in the training data samples. The optimal
set of parameters of the model by minimizing the differ-
ence between model predictions and data labels for the
training instances, with the expectation that the learned
class-discriminative features can be generalized to data
instances outside the training dataset. As we have seen
before, classification, regression, and characterization of
similarities between instances with similar final labels
are some of the most widely used tasks for supervised
18
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machine learning models.
• Unsupervised learning can identify potential patterns in
unlabeled data and clusterize them, by creating a low-
dimensional representation of it. This is useful to iden-
tify outliers in the data. It is important to note that
the identification of low-dimensional representations of
labeled instances can be achieved in a more efficient su-
pervised manner, but the labeling is always an expensive
task in terms of expert effort, cost and time consump-
tion. Commonly to all the DL algorithms, Unsupervised
DL methods need also a wide training dataset, that con-
tains input data but do not require labels.
2.3 Deep Learning tasks
As mentioned earlier, there are many different tasks that deep
learning algorithms attempt to solve. Each of these goals is
usually defined through the definition of a loss function, or
objective function. This allows to evaluate and quantify, dur-
ing each iteration of the training algorithm, the error that the
network commits in predicting the expected result with respect
to a certain input x. In the following we will denote by y the
prediction of a neural model M(·) with respect to x, and by
ŷ the expected label result. As described above, ŷ will only
be available for supervised tasks. The training algorithm of a
neural network aims, therefore, to find a configuration of the
model parameters for which the loss function is minimal. The
evaluation of the loss function itself is the means that provides
the direction of updating of the parameters. How is this pos-
sible? By calculating the gradient (i.e., the derivative) of the
function with respect to each model parameter and updating
them by a gradient descent based rule, for example Stochas-
tic Gradient Descent. Stochastic gradient descent (SGD) is a
way to minimize some objective function L(Θ, xi, ŷi), in which
the arguments are model’s parameters Θ and the i-th input-
label pair in the training set, by updating the parameters in
the opposite direction of the gradient of the objective function.
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In other words, by following the direction of the slope of the
ideal surface outlined by L(·), the error will be downhill until
it reaches a valley. We can describe the update step as
Θ = Θ− η · ∇ΘL(Θ, xi, ŷi) (2.1)
where η is the learning rate. The learning rate is an hyper-
parameter of the training process, it can be interpreted as how
much the evaluation of L(Θ, xi, ŷi) influences the network pa-
rameters each training iteration.
Now we can see some widely used cost functions to solve
deep learning some tasks.
• Multi-class classification: Each image, or sample, can
belong to one of C classes. This task is treated as a single
classification problem of samples in one of C classes. The
ground truth (or label) ŷ is represented by a one-hot
vector t with a single positive class. Usually, the ANN
M have C output neurons, one for each class, and we
referenced it as y. The common choice for this task is
to use a Categorical Cross-Entropy (CCE) loss. The
CCE loss compares two given probability distribution
(y and t in our case) and it have his minimum when
y = t. In order to use the CCE as L(·) function, we need
to define σ(·) as the softmax function. σ(·) basically








where i is a given class index. σ(yi) gives the probability
of predicting the class i for y = M(Θ, x). Therefore CCE




ti · log(σ(yi)) (2.3)
Note that t is a one-hot vector, so the CCE is evaluated
only for the true label ŷ. By adjusting Θ to minimize the
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cross entropy function, we find a configuration in which
y − t < ε, where ε is a low error value.
• Multi-label classification: Each sample can belong to
more than one class. The target vector t will be not
an one-hot vector, and it can have more than a positive
class. This task can be seen the sum of independent clas-
sification problems, where each output neuron decides if
a sample belongs to a class or not. In this case cross
entropy loss can be used, in its binary formulation, but
not the softmax function: we do not want to predict ex-
clusively a single class, but each class can be predicted
exclusively. The σ(·) function, in this case, is the logistic
function. It can be used to transform the ANN output y
into a vector of independent probabilities, therefore each





Straightforwardly, the total loss value have to be the
mean of the cross entropy applied to each y indepen-
dently, therefore binary cross entropy (BCE) is defined
as




ti · log(σ(yi))+(1− ti) · log(1−σ(yi))
(2.5)
• Image generation: For each example x we want to gen-
erate an image y that respects certain characteristics. In
this case ŷ can be a segmentation map, a binary map, or
even x itself. Therefore, ŷ has a cardinality (or number
of pixels) that is a some function d(·) of the cardinality of
x: |ŷ| = d(|x|). A neural network designed for this task,
usually CNN, produces an output y for which |y| = |ŷ|.
Usually ŷ has values in range [0, 1], a sigmoid function
has to be applied to y values. For this kind of problems,
a standard objective function choice is the mean squared
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in which n is the number of ŷ pixels and σ(·) is the logit
function defined in Eq. 2.4. Note the mean squared er-
ror loss is proportional to the `2 norm function. Other
regression losses can be obtained changing the exponent
value. In this case, the error of each output neuron con-
tributes to evaluate the mean error evaluation. MSE
minimal value is 0 when y = ŷ. By finding a configura-
tion for parameters Θ, that minimizes MSE, the model
M(·) generates images y which are very similar to ŷ.
In the following chapters, by exploring in detail some Deep-
Health AI use-cases, we will encounter two different types of





3.1 The regularization problem
Training a deep neural network with high generalizationis a
challenging task. A model with too few parameters will fail
to learn the problem in its complexity, while a model with too
much power will learn not only the data features but also it can
retrain the whole dataset. In both cases, we get models that
generalize poorly to unseen data samples. Next, we briefly dis-
cuss the problem of overfitting in neural network training and
how it can be solved (or mitigated) by performance-enhancing
regularization techniques [11]. As we seen before, the goal of
training a NN model is to have a predictor that can performs
well on training samples as for external data, in the same do-
main, that make the predictor useful in real applications.
"The central challenge in machine learning is that we must
perform well on new, previously unseen inputs — not just
those on which our model was trained. The ability to per-
form well on previously unobserved inputs is called generaliza-
tion." [31]
The model is designed to learn from known cases and gener-
alize these known cases to new cases in the future. Techniques
such as K-fold cross-validation or train/validation/test splits
are used to evaluate the ability of the model to generalize to
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new data. Learning and generalizing to new examples is dif-
ficult: if too little time is spent on training, the model will
perform poorly on the training dataset and on new data and
the model will be not able to scale to the given problem. This
can be referenced as an example of underfit model and it is
is characterized by high bias and low variance. Otherwise, if
Figure 3.1: Visual representation of solutions given by model
with high bias or variance. The picture is taken from
Moradi et al. [58]
too much time is spent on training, the model will perform
too well on the training dataset, but it will have inaccurate
predictions on the new data: this is an occurrence of overfit
model. It has low bias and high variance. The model perfor-
mance can varies widely even with statistical noise added to
samples in the training dataset. In both cases, the model does
not generalize.
"In order to generalize well, a system needs to be suffi-
ciently powerful to approximate the target function. If it is too
simple to fit even the training data then generalization to new
data is also likely to be poor. [...] An overly complex system,
however, may be able to approximate the data in many differ-
ent ways that give similar errors and is unlikely to choose the
one that will generalize best ..." [63]
We can solve the problem of underfitting by improving the
capacity of the model: the capacity refers to the ability of the
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model itself to handle different features; the greater the capac-
ity, the more types of features the model can handle and trans-
form the inputs into outputs. The performance of a model can
be easily improved by changing the architecture of the model,
such as adding more nodes in its layers, adding more layers
and/or substituting them. Because poorly fitted models are
easy to deal with, it is more common to find overfitted mod-
els. An overfit model can be easily diagnosed by evaluating the
model on both the training dataset and the validation dataset
and examining the model’s performance during training. If we
maintain a graph for model performances during the training
phase, we can see what is called learning curve or training er-
ror. A good fit model should have a low training error and
a low validation error. If the model has a high training error
and a low validation error then it could be an overfit model.
For example, the loss curve of the model on the training and
validation datasets (which we try to minimize) shows a line
for the training dataset that drops and may reach a plateau
(learning curve), while a line for the validation dataset first
drops and then starts to rise again at some point.
"As training progresses, the generalization error may de-
crease to a minimum and then increase again as the network
adapts to idiosyncrasies of the training data." [63]
At the very end, we want boosting performance but also
we want to prevent data overfit. Regularization is a way to
introduce constraints to parameters: the learning algorithm
finds difficulties to both fit the constraints and learn entirely
the available data. This “auxiliary information” can be very
valuable to the learner when the data itself is insufficient. In
general, each part of the learning process or prediction pro-
cedure that is added to reduce flaws in the data, is called
regularization. In fact, the regularization process reduces the
variance of the model by assuming some sample’s correlation
exists. In machine learning, we can separate the sampled data
point into two parts: the description and the random noise.
Any machine learning algorithm must be able to model the
description and ignore the noise. Also, algorithms that focus
on fitting noise and features as well as the description, cre-
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ate model overfit [58]. In this case, regularization allows us to
address the model complexity choice, so that the model can
make better predictions the future. Deep models are capable
of learning complex representation spaces, which are needed
to solve complex learning problems. However, the depth and
capacity of the model needed to cover such representations is
often excessive. Therefore, the development of new efficient
regularization methods is inevitable to solve the problems of
model overfitting and generalization. These techniques are
critical features that have to be taken into consideration by
developing a learning algorithm based on training deep neu-
ral networks. These regularization strategies can be divided in
different families, so a more structured grouping is needed.
• Regularization by data manipulation: the concept is to
manipulate the images (or whatever kind of data ) that
feed the neural network during the training loop. The
aim is to make the training robust to input perturba-
tion during the inference phase. This regularization fam-
ily includes all data augmentation techniques as affine
transformations like flip or rotation and domain specific
transformations ( like contrast enhancing, color jiggling,
grayscale transformation, etc.. for images ). Also crop-
ping, adding gaussian noise or input dropout fall into
this category. The aim is the same as before, reached by
hiding random features.
• Regularization by architecture selection: each task and
dataset can require a specific artificial network architec-
ture that fits properly to the purpose. By regularization
through architecture selection, we do not just refer to se-
lecting state-of-the-art model architectures. All different
choices of layers (convolutions, pooling layers, dropout)
or layer blocks, by which we can edit or compose models,
are also included. The design of a network can also be
a simplified or pruned [86, 87] of well known models or,
otherwise, doesn’t have to follow a specific model.
• Regularization by optimizer choice: Lin et al. [52] shows
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how the objective function “sharp” minima does not gen-
eralize as well as “wide” minima; by choosing between dif-
ferent and properly designed optimizers, we can avoid to
stuck our training loop in a local or “sharp” minima [44],
like Adam [45] or SGD. Beside the optimizer, we include
in this regularization family also network initialization
techniques together with early stopping and cross vali-
dation techniques.
• Regularization by loss term regularizer: to the global
objective function (also called loss or cost function ), a
weights constraint term is added. The simplest and per-
haps most common regularization method is to add a
penalty to the loss function in proportion to the size of
the weights in the model. This approach will minimize
the cost function in the train loop, by taking in consid-
eration also these constraints and boosting the general-
ization performances. `2 regularization is a widely used
representative for this category.
"Unless your training set contains tens of millions of ex-
amples or more, you should include some mild forms of regu-
larization from the start." [31]
3.2 Post Synaptic Potental
Generalization improvement of prediction results is always the
main goal and challenge in training a predictive model such
deep neural network. During this enthusiastic deep learning
era, several tricks and techniques, aiming to boost model per-
formances on unseen data, have been proposed. Research effort
can not be confused to the more general deep neural network
architecture enhancing, which also increase generalization per-
formances, and helps the model evolution through time, from
AlexNet [49] to VGG [77] or ResNet [35] and much more in
the years that followed. Just to name some performance boost-
ing examples, that are retrieved from state of the art training
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pipeline, we can cite data augmentation techniques in the in-
put domain, or neural networks layer, such Dropout-[82] or
Batch Normalization [39]. In addition, many other refinements
have been proposed with the same objective, like optimization
methods [16, 45], or even cost function regularization like `2 (
also known ad weight decay) regularization.
Of course, during the experimentation and exploration of
such techniques and their effective application to our context,
we face benefits and disadvantages. `2 or weight decay regular-
ization is generally used combined with other types of regular-
ization choices. This method has been widely used in the train-
ing of most artificial neural networks and even with its simple
formulation, it improves generalization to various scenarios.
About this topic, similarity was observed between weight de-
cay and dropout by Wager et al. [90]. By investigating the
meanings and underlying implications of `2 regularization, we
figured out a novel technique that achieves more sophisticated
learning strategies performances and we called it PostSynap-
tic Potential regularization (PSP) [6]. Like weight decay, PSP
falls in the large regularization family by loss term regular-
izer. The following subsection is dedicated to the definition
of PSP and to the underlying theoretical explication. Images,
notation and experiments are taken from the original publica-
tion Post-synaptic Potential Regularization Has Potential at
ICANN2019 ) [6].
3.2.1 PSP definition
In order to define PostSynaptic Potential regularization, we
have to introduce some notation that help us to understand
how it works. Let our artificial neural network to be an acyclic,
multi-layer, for a total of N layers, where layer l = N the out-
put layer and l = 0 is the input layer. The set of all trainable
and trained parameters in the neural network is defined in
Sec. 2.3 as Θ. Let the l-th layer contain Kl neurons. If the the
l-th layer is a convolutional layer, Kl will be the the number of
filters. Therefore, let k ∈ [1, Kl], we consider the k-th neuron
in the l-th layer with:
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• yl−1 as input vector.
• yl,k as its own output signal.
• Θl,k as its set of parameters: bl,k is the neuron bias,
while wl,k are the weights. The j-th weight is identified
as wl,k,j
An affine function fl,k(·) takes the weighted input vector.
This affine function can be a dot product, convolution, batch
normalization or any of their combination. An activation func-
tion ϕl,k(·) is applied later to produce the neuron output. So,
the neuron output can be expressed by
yl,k = ϕl,k [fl,k (Θl,k,yl−1)] (3.1)
The (3.1) is simplified by defining the post-synaptic potential
zl,k as
zl,k = fl,k (Θl,k,yl−1) (3.2)
Post-synaptic potential can also be referred as the pre-
activation potential. Hence, the core of this regularization
strategy is zl,k, that is the main actor of the following analysis.
Figure 3.2: Representation of a neuron. In this schema zl,k,
or also the post-synaptic potential, is reported. The image and
the notation is taken from Tartaglione et al. [6]
A graphic summary of the above notation is reported in
Fig. 3.2.
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3.2.2 Weight decay consequences
on the post-synaptic potential
We have to introduce first the well-known `2 regularization











Together with the objective function L(·), Eq. (3.3) is mini-
mized. The overall minimized function J(·) is defined as:
J(Θ, x, ŷ) = ηL(Θ, x, ŷ) + λR`2(Θ) (3.4)
where η, λ are positive real numbers, commonly in range (0, 1),
and ŷ is the desired output. The back-propagation strategy is
used to compute all the update contributions to the weights.
Let the focus be the regularization term (3.3), minimizing it
corresponds to adopt the commonly named weight decay strat-
egy. The update rule for weight decay is the following:
Θt+1l,k,j := (1− λ)Θ
t
l,k,j (3.5)
This obviously generates perturbations of the output for the







How does the `2 regularization influence zl,k?
If we minimize (3.3), we expect Θl,k,j → 0∀l, k, j. Now, if we
have an input pattern for our network y0, it is straightforward,
according to (3.2) and (3.5), that zl,k → 0, because all the pa-
rameters Θl,k will be zero.
This conduces to thinking to the effect to weight decay, if
zl,k → 0, the output of the neuron yl,k will have a limited
range of values, because yl,k → ϕ(0). This is a characteristic
region in the mostly-used activation functions: for the ReLU
activation we are close to the derivative discontinuity of the
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function, while, in the case we use sigmoid or hyperbolic tan-
gent, we have the maximum value for the zl,k derivative. If
focusing on this region is the reason why weight decay boosts
the performance in generalization, we can formulate a regular-
ization term in which |zl,k| is minimized explicitly.
3.2.3 Post-synaptic regularization
We have observed that, if we take into account the typical deep
learning scenario, the weight decay regularization minimizes
the post-synaptic potential of the neurons, by focusing the
output of each neuron around some characteristic regions. This
might help the back-propagated signal and, indirectly, favor
the generalization performances.
If we impose an `2 regularization on zl,k, we will explicitly drive
the post-synaptic potential of the neuron and its output yl,k.










where k is an index ranging for all the neurons in the l-th layer.






What is the perceived update by the parameters of our model?
We can check the update contribution by using the chain rule
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Bias and weight cases are slightly different. Let Θl,k,j the bias,














Otherwise, let Θl,k,j be one of the neuron weights. The
derivative, by isolating wl,k,j contribute from the summation











































where Cl,k,j is the contribution to zl,k from all the parameters
except for wl,k,j. By assuming
∂zl,k
∂wl,k,j
= 1 and Cl,k,j = 0, we
can recover the weight decay formulation.





We can see that zl,k is a bounded term, because we are mini-
mizing (3.7). In addition, we need to distinguish between two
different cases for y(l−1,j):
• l 6= 1: y(l−1,j) is defined as the output of the (l − 1)-th
layer: if the post-synaptic potential is minimized also
in previous layers, taking into account commonly-used
activation functions, it is definitely a bounded quantity.
32
CHAPTER 3. REGULARIZE DEEP NEURAL
NETWORKS
• l = 1: in this case, y(0,j) represents the network input,
which we assume to be bounded.
Hence, also (3.13) is a ranged quantity, because it defined as
product of bounded quantities.
However, we want to minimize the whole sum in (3.7), rather
than (3.8). By explicitly writing the regularization contribu-
tion to the parameter Θl,k,j and by considering R application







and that take us into the analysis of three different cases:
• p = l: the gradient term ∂zp,h∂Θl,k,j = y(l−1,j) if h = k, zero
otherwise. The regularization effect on a neuron is not
affected from adjacent neurons in the same layer.
• p < l: the gradient term is ∂zp,h∂Θl,k,j = 0 and its contribution
falls to zero.
• p > l: in the most interesting case, our regulariza-
tion applied to the last layer affects all the previous
ones. All the network parameters on previous levels re-
ceive a contribution for each following regularized level.
By back-propagation, such contribution is automatically
computed.
If we take in consideration the general case, the whole update
contribution, resulting by minimize (3.7), on the k-th neuron’s















1 if Θl,k,j is bias
y(l−1,j) if Θl,k,j is weight
(3.16)
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In order to better understand the above update contribution,
a graphic visualization is shown in Fig. 3.3. So we have seen
how a post-synaptic potential regularization, which minimizes
zl,k explicitly, works in all the neurons of an artificial neural
network. The analysis shows how the update term for a param-
eter includes global information employs a global information
originating from succeeding layers. This “feedback” favors the
regularization itself.
Figure 3.3: Representation of the update contribution in
Eq. 3.15. By considering the on the k-th neuron (blue ar-









contribution from subsequent layers (red arrows). Therefore,
the parameters in previous layers are tuned to regularize z also
in following layers.
3.3 PSP experiments
We report the performance reached by some of the commonly
used artificial neural networks by applying our post-synaptic
potential regularization (PSP). We compare those perfor-
mances to the results obtained by applying weight decay.
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We tested our regularization techniques on three different
datasets: MNIST, Fashion-MNIST and CIFAR-10 by using
LeNet5, ResNet-18 [35], MobileNet v2 [71] and All-CNN-
C [81] architectures. For each reported training result, the
used model hyper-parameters are selected by using grid
search over multiple initialization seeds. All the simulations
are performed using the standard SGD with CUDA 8 on
a NVIDIA Tesla P-100 GPU. Our regularization has been
implemented using PyTorch 1.1.1
We start by showing our attempted to train the widely studied
LeNet-5 model over the standard MNIST dataset [51]. The
MNIST dataset is a database of digitized handwritten digits,
in form of 28x28 pixels grey-scale pictures. This database is
provided with 60k training images and 10k test images. We
use SGD with a learning parameter η = 0.1, mini-batch size
100. The training lasts here 50 epochs. In Fig. 3.4, we show
a typically observed scenario in our experimental setting,
where we compare standard SGD optimization strategy
without using any regularization, the effect of both `2 and `1
regularization ( by using hyper-parameter λ = 0.0001), the
effect of dropout regularization on the network ( by using
a commonly used drop probability p = 0.5) and our pre-
activation signal potential regularization (PSP, λ = 0.001).
The results are shown in Table 3.1, that reports the obtained
classification errors, averaged on 10 different runs along with
the corresponding standard deviation. While the weight decay
average performance is 0.74%, PSP performance is 0.55%.
Please note that this result is deemed statistically significant
since the t-test rejects the null hypothesis that there’s no
difference between the means with p-value in order of 10−5.
We would like to emphasize that, using this simple training
strategy, the performance reached on LeNet-5 is among the
best recorded, nevertheless having a much lower computa-
tional complexity [16]. We find interesting the behavior of〈
z2
〉
for all the three techniques (Fig. 3.5). In the case of




value, as it is not controlled,
1All the source code is publicly available at https://github.com/EIDOSlab/PSP
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typically grows until the gradient on the loss will not be zero;
the same behaviour is shown for dropout regularization. For
`2 regularization, interestingly, it slowly grows until it reaches





is extremely low, and still slowly decreases. According to the
results in Fig. 3.4, this is helping in the generalization.





















Figure 3.4: Error on the test set during the training phase. We
report the average error across multiple network initialization
seeds. Vertical lines indicate the standard deviation on error
values.
We want to have a further look at what is happening at
the level of the distribution of the parameters layer-by-layer.
A typical trained parameters distribution for LeNet5, trained
on MNIST, is shown in Fig. 3.6. While `2 regularization typ-
ically shrinks the parameters around zero, PSP regularization
does not constrain the parameters with the same strength,
while still constrains the pre-activation signal (Fig. 3.5). How-
ever, contrarily to this, the first convolutional layer, with `2
regularization, is less constrained around zero than with PSP
(Fig. 3.6a). Such a behavior can be explained by (3.15): all
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Figure 3.5: Performance comparison in LeNet5 trained on
MNIST between `2 regularization, `1 regularization, dropout
and post synaptic potential regularization (PSP). All the plots
show an average on 10 runs. The graph shows Average values
for z2. Vertical lines indicate the values standard deviation.
We can see how these are almost invisible in the case of using
PSP.
the regularization contributions coming from all the forward
layers (in this case, conv2, fc1 and fc2) affect the parameters
in conv1, which are directly conditioning all the z computed
in forward layers.
As a further step, We decided to test LeNet-5 on a more
complex dataset: hence, we have chosen the Fashion-MNIST
dataset [96]. It is made of 10 classes of 28×28 grey-scale
images representing various pieces of clothing. They are
divided in 60k examples for the training set and 10k for the
test set. Such a dataset has two main advantages: the problem
dimensionality (input, output) is the same as MNIST; hence,
the same ANN can be used for both problems, and it is not
as trivial as MNIST to solve. Training results are shown in
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(a) First conv. layer (conv1) (b) Second conv. layer (conv2)
(c) First fullyconnected layer (fc1) (d) Output layer (fc2)
Figure 3.6: Typical distribution of the parameters in a LeNet5
trained on MNIST with `2 regularization and with post synap-
tic potential regularization (PSP). We can see how PSP usage
pushes the top layers parameters to a more homogeneous value
distribution than `2.
Table 3.1. The simulations are performed with η = 0.1, batch
size 100 and λ = 0.0001 for both `2 and `1 regularization
while λ = 0.001 for PSP.
The training lasts here 150 epochs. Here, the difference in
the generalization between `2 and PSP is wider than the one
presented for MNIST: we are able, with the same architecture,
to improve the performance by around the 1% without any
other heuristics.
Moving towards deep architectures, we decided to use
CIFAR-10 as dataset. It is made of 32x32 color images (3
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Table 3.1: Classification error on LeNet-5 for MNIST and







channels) divided in 10 classes. The training set is made of
50k images and the test set of 10k samples. This dataset is a
good compromise to make the first tests on deep architectures
as the training is performed from scratch.
Three convolutional architectures have been here tested:
MobileNet v2 [71], ResNet-18 [35] and All-CNN-C [81]. In
order to separate the contribution of our regularizer towards
other state-of-the-art regularizers, we are going to compare
our results with our baseline (same data augmentation, no
dropout). All these networks were pre-trained with η = 0.1
for 150 epochs and then learning rate decay policy was
applied (drop to 10% every 100 epochs) for 300 epochs.
Mini-batch size was set to 128 and momentum to 0.9. For
standard training, the `2 λ was set to 0.0005 while for PSP
regularization to 0.001.
All the results are shown in Table 3.2. Please note that
Table 3.2: Top-1 classification error on CIFAR-10 (Error %)
Architecture `2 PSP `1
Dropout
(p = 0.1)
ResNet-18 5.1 4.6 6.2 6.4
MobileNet v2 7.0 6.4 6.9 7.7
All-CNN-C 9.1 8.6 9.4 N/A
ALL-CNN-C includes by design some dropout layers, having
p = 0.5; as a consequence, all the presented results for
this architecture includes dropout. Our results show that
PSP-based regularization generalizes better than `2, `1 and
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4.1 Histopathological tissue diagnosis
Histopathology literally refers to the study of tissues associ-
ated with some disease. Histopathology is the study of organic
tissues and the analysis of biopsies, performed by a patholo-
gist. Therefore, it is also the examination of tissues under a
microscope for signs of disease. In clinical medicine, it refers
specifically to the examination of specimens from biopsies or
surgical procedures that are processed by a pathologist and his-
tological sections are placed on glass slides. The histopathol-
ogy report describes the microscopic features of the tissue and
cancer sent for examination. Therefore, histopathological re-
ports are sometimes referred to as “biopsy or pathology re-
port”. Pathological examination of tissue begins with surgery,
biopsy or autopsy. Tissue is removed from the body or plant,
usually freshly dissected by a specialist, and then placed in a
fixative to stabilize the tissue and prevent degradation. The
most common fixative is formalin. A physician who special-
izes in microscopic examination is called a pathologist. The
tissue to be examined is taken from a biopsy or surgical pro-
cedure, and a sample of the suspect tissue is selected and sent
to the laboratory. The tissue is then cut into very thin layers
(called sections), stained, and examined under a microscope
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to reveal the details of the cells in the tissue [33]. This can
be done on chemically fixed slides or frozen section slides. In
order to examine the tissue under the microscope, the slides
are stained with one or more stains. The purpose of the stain
is to show the cellular composition, and the contrast color is
used to create contrast. Histochemistry is the science of study-
ing the chemical reactions between laboratory chemicals and
tissue components. The most common stain used in histology
is a combination of hematoxylin and eosin (often abbreviated
as H&E). Hematoxylin is used to stain the nucleus blue, and
eosin is used to stain the cytoplasm and extracellular connec-
tive tissue matrix pink. There are hundreds of other methods
to selectively stain cells. Saffron, silver salts and artificial dyes
are also other techniques used to stain tissue sections. On the
other hand, histopathological sections provide a more complete
picture of the disease and its effect on the tissue because the
basic structure of the tissue is preserved during the creation
process. Thus, disease features, such as lymphocytic infiltra-
tion of cancer, can only be inferred from histopathological im-
ages [33]. The grading system varies depending on the type
of cancer being evaluated, but is generally based on the ab-
normalities of the cells under the microscope, with low grade
tumors appearing more normal and higher grade tumors show-
ing more abnormalities [72]. In other words, high-grade tumors
are usually tumors with many cellular abnormalities. Grad-
ing is different from staging. The staging of cancer surgery
is related to the part of the body where the cancer is located
and how much it has spread. The importance of quantitative
pathology image analysis has been recognized by image anal-
ysis and pathology researchers. Since most current pathologic
diagnoses are based on the subjective (but empirical) opin-
ion of the pathologist, there is a clear need for quantitative
evaluation based on digital slide images of pathology. Such
quantitative analysis of digital pathology images is important
not only for diagnosis but also for understanding why a par-
ticular diagnosis was made (e.g., specific chromatin structures
in the nucleus of a cancer cell may indicate a specific genetic
abnormality). In addition, histopathological imaging has be-
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come the “gold standard” for the diagnosis of many diseases,
including almost all types of cancer [37]. The appropriate use
of such image processing will enable a more accurate character-
ization of images from a diagnostic perspective. For example,
enhancing cell nuclei features can be indicative of cancer sta-
tus diagnosis. While the additional structures in these images
provide a wealth of information, they also pose new challenges
for automated image analysis.
4.2 AI and histopathological images
Today, automated diagnostics based on medical imaging is
probably the most successful application area for medical AI.
As we said before, any medical specialties, such as radiology,
ophthalmology, dermatology, pathology, etc., use diagnostic
imaging. Histopathological evaluation is the gold standard
for the diagnosis of many cancers. In this process, biopsies
are processed on tissue sections, stained with dyes, and the
sections are then interpreted by expert pathologists based on
visual assessment under a microscope. This process is com-
monly referred to as histopathology. However, differences be-
tween pathologists have been reported [83, 23] and proposed
procedures cannot be easily extended. In addition, extended
studies on histopathological images can only be done by col-
lecting them from multiple source institutions. The ability of
the human expert pathologist to predict survival in cancer pa-
tients [99] suggests that pathology sections contain a wealth of
information that has not yet been exploited. DL models have
been used for classification and segmentation tasks of histo-
logical images since 2012 [40, 78, 97]. Janowczyk et al. [40]
provide a detailed survey on the distribution of the applica-
tion of DL across different pathology domains, like tubule seg-
mentation, mitosis detection and nuclei segmentation. Ad-
vanced applications of automated image processing for mi-
croscopic tissues scans also include detection of metastatic
breast cancer [57, 59], grading gliomas [27], basal-cell carci-
noma [19]. Janowczyk et al. describes well known models,
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such AlexNet[48] and VGG [76], today almost used for bench-
marks. Regarding the colorectal cancer domain, Sirinukun-
wattana et al. [79] present a DL-based method to perform nu-
cleus center detection and classification on four different types
of nuclei from microscopic whole-slides. An extensive litera-
ture is focusing on applying deep learning in image analysis
in order to evaluate endoscopic images for the detection of
polyps [54]. In contrast, a fewer number of studies have at-
tempted to address the challenges of histopathological exami-
nation, by using deep learning analysis, of whole digital slides
for colorectal polyps [47, 80, 92] that are the core of this thesis.
These efforts have yielded promising results, but the sequences
analyzed contain a small amount of samples and, most im-
portantly, no attempt has been made to evaluate both of the
important mandatory features of diagnostic evaluation (i.e.,
histological type and degree of dysplasia) simultaneously. Kor-
bar et al. [47] present a crop-based framework, developed using
a ResNet architecture [34], to classify different types of colorec-
tal polyps from whole-slide images. This work provides em-
pirical suggestions the residual network architecture achieves
better performance than other models. Following their previ-
ous work, Korbar et al. introduce a revised version of Grad-
CAM (gradient driven class activation mapping) [74] to visual-
ize the attention map of the network for the annotated whole-
slide [47].This work was able to show guided Grad-CAM with
boxes can visualize the most relevant and informative regions
for the network, in according with pathologists annotation. A
similar approach can be seen in Kather et al. [43] on colorec-
tal cancer classification. Subsequently Bychkov et al. [12] use
convolutional and recurrent neural network and combine dif-
ferent architectures predictions, in order to predict five-years
probabilities of disease survival, caused by colorectal cancer,
and estimate risk for each individual. Bychkov et al. dis-
cusses the idea of feeding features extracted from CNN im-
age clipping into an LSTM network to use spatial informa-
tion. Due to the high impact of DL frameworks on medical
images processing performances, a modern open-source plat-
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form, ORBIT 1[84] has included also some deep models for
multiple tasks like image segmentation, classification, tissue
quantification. Reyes et al. [65] enhanced data formats to de-
scribe whole-slides at multiple resolution level. Recently the
focus shifted in detecting and predicting polyp type during
colonoscopy without submitting it for histology, saving time,
and costs [101, 75, 94, 13]. Recently, Wei et al. [92] propose
an analysis model to evaluate the automatic predictions of an-
notated tissue. It perform an evaluation of the generalization
capability of neural model across datasets coming from exter-
nal medical institutions. Automated systems can address the
shortage of full-time pathologists [66] and improve the qual-
ity of care for cancer patients through rapid and objective
evaluation of histopathology specimens. In general, success-
ful applications in radiology, dermatology, ophthalmology, and
pathology have used labeled big data, computational power,
and deep learning techniques to achieve expert-level diagnos-
tic accuracy. Applying this research to clinical practice will
not be easy, but it has the potential to fundamentally change
current medical practice.
4.3 Colorectal polyps classification
We already seen how the expansion of cancer screening pro-
grams and the demand of colonoscopy surveillance routines
are leading the gastrointestinal histopathology to grow. In the
medical image processing field, the raw data, e.g. 2D scans
like tissues Hematoxylin & Eosin histology biopsy or 3D scans
like brain Magnetic Resonance, has huge dimensions for each
sample and high variance compared to their diagnosed class of
belonging. By the definition of their collection process, high
resolutions helps the specialist in pathology in his analysis and
diagnostics.
A predictive signal of possible gastrointestinal cancer devel-
opment are colorectal polyps, which are pre-cancerous lesions
located in the lining of the colon. Colorectal tissue samples
1Website www.orbit.bio
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are collected by biopsies and colonoscopies. Gastrointestinal
pathologists examine them to find signs that predict tissue neo-
plastic process and invasive carcinomas. The histopathological
characterization of colorectal polyps allows management cor-
rection, and follow-up, of the patient with the ultimate goal of
prevention or early detection of invasive carcinoma. Colorec-
tal polyps are characterized using histologic analysis of tissue
samples to determine the degree of malignancy and polyp dys-
plasia. Deep neural networks have achieved superior accuracy
in medical image recognition, but they require large sets of
annotated images for training.
Within DeepHealth, a corresponding use-case is formu-
lated: we focus our effort to develop a neural network-based
pipeline to automatically diagnose colorectal cancers from
Whole-Slide Images (WSI). WSI are super high-resolution im-
ages retrieved by scanning biopsies material, more specifically
Hematoxylin & Eosin-stained slices of tissue, from patients
undergoing cancer screening. These images can reach more
than 100.000×100.000 pixels in their size. This description
is taken mainly from the book chapter we wrote within
DeepHealth activities [4].
The first goal of the use-case is to collect more than a
thousand of labelled and annotated WSI, in accordance with
the evaluation of the UNITO pathologists’ team. The slides
are acquired through a professional scanner “Hamamatsu
Nanozoomer S210” at 20× magnification: the result is an
image with physical/digital resolution image ratio of 0.4415
µm/pixel. Those images have to fit the data demanding for
Deep Learning algorithms, in order to propose a complete and
ready-to-use classification application for histopathological
images.
The WSI corresponds to the whole specimen collected from
the patient: it is provided with a label (the diagnosis) and the
annotation on the subset of tissue taken into consideration
by the pathologist to elaborate the diagnosis (the so-called
diagnostic tissue). The experts collected six different types (or
classes) of tissue:
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• Normal tissue (NORM): biopsies of normal tissue, with-
out any specific disease.
• Hyperplastic polyp (HP): it is a very frequent lesion,
single or multiple, benign, without pre-neoplastic signif-
icance. It is due to an excess cell growth of glandular
components. Hyperplastic polyps usually exhibit no ma-
lignant potential [88], while adenomas are more likely to
progress into invasive carcinomas.
• Tubular adenoma, high-grade dysplasia (TA.HG): it is
a rather frequent pathology with pre-neoplastic signifi-
cance and the risk of neoplastic transformation into car-
cinoma is directly proportional to the number of adeno-
mas and the size of each adenoma. Adenomas are as-
sociated with a grade of dysplasia, which measures the
abnormality in cellular growth and differentiation [38].
The dysplasia is a pre-neoplastic lesion with a high-risk
factor. Higher grade dysplasia indicates higher malig-
nant potential.
• Tubular adenoma, low-grade dysplasia (TA.LG): such
dysplasia degree has a lower risk factor.
• Tubulo-villous adenoma, high-grade dysplasia
(TVA.HG): similar to tubular adenoma, it has a
slightly different macroscopic structure and a major risk
factor.
• Tubulo-villous adenoma, low-grade dysplasia (TVA.LG):
Tubular and tubulo-villous are common colorectal ade-
nomas, with villous adenomas generally presenting
higher malignant potential given the larger surface [88].
Clinical and Surgical Pathology department of University
of Turin provide the labelled set of whole-slide biopsy images
that will be exploited by machine learning experts in the team
for models training and testing on DeepHealth HPC infrastruc-
tures. In the context of DeepHealth, it was possible to publish
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Figure 4.1: Example of Whole Slide Image (WSI)
part of the collected and annotated data in a public dataset
that we called UniToPatho.
4.4 UniToPatho
Figure 4.2: The logo of UnitoPatho
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HP NORM TA TVA Total
HG LG HG LG
Slides 41 21 26 146 20 38 292
σ = 7000 59 74 98 411 93 132 867
σ = 800 545 950 454 3618 916 2186 8699





7.07 13.86 5.55 44.66 9.33 25.98 106.44
Table 4.1: UniToPatho class distribution for whole image
slides (top) and the two patch scales made available (bottom).
UniToPatho [1, 2] is now public dataset of annotated high-
resolution H&E-stained images, comprising multiple histolog-
ical samples of colorectal polyps biopsies scans, collected from
patients undergoing cancer screening. The dataset is a col-
lection of the most relevant patch images extracted from 292
whole-slide images (or simply slides in the following), in ac-
cordance with UniTo pathologists’ evaluation. The slides are
acquired through a Hamamatsu Nanozoomer S210 scanner at
20× magnification (0.4415µm/px), as exemplified in Fig. 4.3.
The following material and figures are taken from the origi-
nal dataset proposal and our following research. [1, 5] Each
slide belongs to a different patient and is annotated by ex-
pert UniTo pathologists, according to six classes as follows,
as mentioned in Sec. 4.3: Normal tissue (NORM), Hyper-
plastic Polyp (HP), Tubular Adenoma with High-Grade dys-
plasia (TA.HG) and Low-Grade dysplasia (TA.LG), Tubulo-
Villous Adenoma with High-Grade dysplasia (TVA.HG) and
Low-Grade dysplasia (TVA.LG).
The UniToPatho dataset contains the slides splitted into a
train set and a test set with a 70% to 30% ratio, by resulting
in 204 slides used for training and 88 for testing. Therefore,
each slide is represented either in the train set or in the test
set, but not in both. Following the approach in [80, 42], we
release square patches cropped from the 292 slides. Whole
Slide images have large resolution and need to be cropped into
patches. From each slide, we crop multiple non-overlapping
square patches at different scales. We denote the side of the
49
CHAPTER 4. COLORECTAL POLYPS
CLASSIFICATION
(a) NORM (b) TA.LG (c) TA.HG
(d) HP (e) TVA.LG (f) TVA.HG
Figure 4.3: Example of 800×800µm patches for the six Uni-
ToPatho colorectal polyps classes.
underlying physical area with σ, measured in µm. The number
of patches obtained for each slide hence depends on multiple
factors including σ, the slide size and the polyp type. As
common in similar datasets, the different classes are highly
unbalanced in the dataset.
We make publicly available a total of 9536 patches, 8669 of
which extracted at σ = 800 (1812×1812 pixels patches) and
867 at σ = 7000 (15 855×15 855 pixels patches). Tab. 4.1 pro-
vides a summary of the class distribution for the whole slides
and the released patches. For each crop, the dataset maintains
its slide index. This index is used to compose our subsets with-
out intersection between patients. Each slide is associated with
some metadata (stored in NanoZoomer Digital Pathology An-
notations .ndpa file format), including a collection of Region
of Interests (RoIs) associated with the corresponding class (see
Sec. 4.4.2). Each RoI is determined by the pathologist and is
defined by a free-hand contour, identifying the tissue area ex-
hibiting histological findings. The number and the size of RoIs
is highly variable and depends on both the tissue availabil-
ity and the histological analysis. Such heterogeneity unfortu-
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nately, leads to dataset unbalancing. Moreover, the collection
and scanning of these slides cannot be homogeneous: As an
example, the number of biopsy with Normal diagnosis is small
compared to Tubular Adenoma cases, because biopsy is per-
formed only on already suspicious areas. This difference is
typical of the analysis process: if the presence of adenoma is
not assumed, the biopsy is not prescribed. In our dataset, the
distribution of the tissue data by classes is shown in Tab. 4.1.
In the table the first rows represent the number of slides and
the last one total tissue annotated area A for each class, re-
spectively. We say we have R RoIs, which can be sliced into
P patches. Therefore, annotated tissue area is At = area(Rt),
where t is the tissue class index. The UniToPatho patches P
are cropped from R with a sliding window approach. A simple
colour thresholding method discards the background patches.
4.4.1 Data collection
The data collection for the Deephealth use case colorectal
polyps classification continued beyond publication of the
dataset UniToPatho, by including new expert annotators
for the biopsies samples. Tab. 4.2 shows the current data
collection status. Moreover, it can be noted that the number
of slides, reported in Tab. 4.2, denotes the frequency of
appearance of the diseases, which is different for each one.
The diagnostic hypothesis preceding the biopsy affects instead
the amount of tissue taken from the patient, thus the amount
of diagnostic tissue. Tab. 4.4 and Tab. 4.5 show different
statistics in the Region of Interest analysis on the whole
data collection. From these graphs it is easy to see how
much the amount of relevant diagnostic tissue correlates
with the type of colorectal polyp present in the biopsy. For
example, slides containing tubular villous adenomous material
(TVA) have much larger annotations than the other classes.
This is due to the morphology of the pathology itself: the
tubulo-villous adenoma presents macroscopic morphological
characteristics, observable with a low magnification of the
tissue, that differentiate it from the tubular adenoma.
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HP NORM TA TVA Total
HG LG HG LG
Slides 108 30 126 534 129 104 1031





18.74 18.38 58.29 154.59 265.65 109.63 625.30
Table 4.2: Class distribution for whole current image slides
collection (top), the relative number annotated Region of In-
terest (RoI) (middle) and annotated underlying relevant tissue
area.
In Fig. 4.4 is presented an overview of the diagnostic tissue
that our pathologists annotate on the available slides. We
can clearly see how the total data collection is unbalanced,
due to the frequency of each patient disease. Fig. 4.5 shows
the same data by looking the mean amplitude of the RoIs for
each class. Both graphs show how different polyp types have
relevant differences in available diagnostic tissue for a single
slide.
Figure 4.4: Visual report of unbalance in available diagnostic
tissue. We take in consideration only the annotated tissue area
as diagnostic.
4.4.2 Processing annotations
As we already mentioned in Sec. 4.4, the annotations are pro-
duced with the NanoZoomer Digital Pathology Annotations
software and a single metadata file in .ndpa file format is pro-
duced for each slide. There is very poor documentation on
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Figure 4.5: Diagnostic tissue distributions for each class. As
in the Fig. 4.4, we consider the diagnostic tissue as the RoIs
area.
how to handle this proprietary format without the proprietary
Hamamatzu viewer software, so we want to suggest here some
simple guidelines.
Basically, the .ndpa file can be read and processed as
.xml file. It presents a list of <annotations> tags, each
one describe a different annotation (called RoI in our case).
Each <annotation> tag can have different type attribute,
like freehand,rectangle,circle, and provides the coordi-
nates of each perimeter point. Let A be an annotation and S
the reference slide scan, you have to access to both to get the
correct tissue slice:
• manage the coordinates format: A coordinates are ex-
pressed in nanometers (nm), while S express coordinates
in pixels (px) and provide the acquisition resolution in
µm/px. In order to read the slide patches correctly, this
conversion needs to be handled.
• manage coordinate reference: A points coordinates can
be found with positive or negative values: A reference is
the center of S. Instead, the S pixel coordinate reference
is in top-left corner. The A reference can be found by
applying the coordinate transformations from S dimen-
sions or, if they are available, by using S XOffset and
YOffset properties (expressed in µm).
In Fig. 4.6 an example of multiples RoIs, in a single slide, is
shown.
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In this chapter we are going to see how to take care of
the healthcare task related to histopathological diagnosis
presented in the previous chapter. First, we present an
in-depth study on how the histopathologic tissues collected
within DeepHealth are suitable to solve this task, then some
consideration on how to take in account data unbalance in
tissue image preprocessing. The descriptions, considerations
and the images reported below are taken from our related
work [5].
5.1 Study method pipeline
The usage of deep learning for classification already proved, in
similar learning tasks, to be extremely effective and robust [47,
92]. How we have already seen in Sec. 4.4 direct classification
on the (high resolution) whole slide, in our context, is unfeasi-
ble: the relevant features are local and can be detected at very
low image scale. For this reason, the deep learning model is
not trained on the full slides, but on some crops we refer to as
patches (Sec. 4.4.2). High-level representation of our approach
is reported in Fig. 5.1. The tissue outside the RoIs contains less
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RoI Slicing in patches Neural networkWSI Patches pre-processing
Prediction on
single patches RoI WSI
Prediction on
Figure 5.1: The neural network is trained on RoI images (gears
symbol) and tested on WSI (lock symbol).
salient features for the overall classification task (or even differ-
ent type tissue of organic tissue) and should be ignored. Hence,
in our training pipeline, we use patches extracted from RoIs
only. In our work [5], once the model is trained on patches’
classification, we use the average score from all patches to infer
a prediction for the starting whole slide in the test set.
The first operation we perform on RoIs (even before slicing
them into patches) is re-scaling them, in order to fit the cho-
sen model input resolution to some target physical resolution
σ, by using the Lancos-3 filter (as it produce slightly sharper
results than bicubic method) [64]. We chose to use a input im-
age resolution compatible with current CNN models, typically
working on images with hundreds of pixels per row/column.
In this study, we choose to slice the RoIs/WSIs tissue area
At into 224 × 224 pixels large patches with some overlapping
area Ât, where t identifies the class. The inclusion of Ât in the
patches extraction process wants to compensate the imbalance
in At ∀ t in less represented classes [93]. This is also a type
of regularization by data manipulation, as we seen in Sec. 3.1.
If we consider P as the total set of tissue patches, we want
all |Pt| to have at least the same order of magnitude, by gen-
erating overlapping images. We address this by changing the
sliding window stride for images belonging to less represented
classes. By reducing the stride, we add tissue redundancy be-
tween patches, or Ât.
stride(t) = 1− 1/max(1, (âP̂t/At)β) (5.1)
where t identifies the class, P̂t is the expected number of
patches for class t and â is the single patch area. Since P̂t
represents the expected |Pt|, that is set to the average patch
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number from most represented classes. β hyperparameter
regulates the stride lower-bound. During training we augment
data: we include vertical/horizontal flips and a random
operation chosen between rotation, equalization, solarization,
inversion and contrast enhancing, as proposed in [20]. The
solarization function randomly transforms the image by
inverting all pixel values above a given threshold. Data
augmentation is crucial for training a neural network in this
context. The variability of the dye, the quality of the scans
and the shared features from tissues of the same patient, are
obstacles to a good solution able to generalize well. Without
data augmentation there is an increased risk of producing
overfitting neural models.
In order to perform classification on the patches, we have
used ResNet-18: it represents a good trade-off between com-
plexity and performance and is one of the broadly-used to
solve similar tasks [47, 92]. ResNet’s architecture high per-
formances come from its block compositions, called residual
blocks (Fig. 5.2). It is a block of convolutional layers that is
learned via back propagation as part of a larger network. The
final layer of the residual block is called the merge layer. It
uses the learned parameters to merge the outputs of the con-
volutional layers. It is also interesting that ResNet’s initial
layers are also designed to be “deep”, meaning that they have
a large depth. This is the opposite of the common strategy
of using shallow architectures to train deep neural networks.
Pre-trained deep neural networks (on the ImageNet classifica-
tion task) can be effectively used as initialization for medical
classification tasks, showing good performance [47]. 1
5.1.1 Patches normalization studies
We perform a study at different RoI phisical resolutions: the
goal here is to identify the best scale the deep model is able to
extract the useful features to predict correctly the slide label
from a single tissue patch.
1Pre-trained model used in all the experiments is available on PyTorch website.
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Figure 5.2: Scheme for a ResNet’s residual block. It is an exam-
ple of shortcut or skipping connections. Shortcut connections
are those skipping one or more layers, by performing identity
mapping, and their outputs are added to the outputs of the
stacked layers. Their main advantage is to forward an high sig-
nal gradient to the previous layers in back propagation during
the training phase. The image is taken from He et al. [35]
A common step for microscopy image analysis is color nor-
malization. This process reduces the differences in tissue sam-
ples due to variation in staining and scanning conditions. To-
wards this end, we consider 8 possible patches resolutions σ ∈
[300; 1000] µm, and 3 possible input preprocessing strategies:
use of the original patches (RGB), conversion to gray-scale
(gray) and the use of a standard slide normalization strat-
egy (Macenko et al. [55]), resulting in 24 training possibilities,
which are reported in Fig. 5.3. For our classification task, we
Figure 5.3: Classification performance at patches level. The
source dataset was a slight different slide collection from Uni-
ToPatho. The dataset is divided into patches by following the
same criterion for different physical resolutions.
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found that the use of gray-scale images does not remove useful
information (which might be embedded in the color) and, on
the contrary, helps in removing the expected color bias [56,
69]. From our results we learn that, for the particular classifi-
cation task we aim at solving, the the signal strength is one of
the most relevant features in the image texture and, while the
direct use of the RGB image does not compensate the color
bias, or even standard slide normalization strategies, like [55],
destroy some useful information which is not embedded in the
color feature. For these reasons, we focus the analysis pre-
sented in [5] by using gray-scale patch images as input.
5.1.2 Preliminary patches resolution and
WSI classification studies
Here we will inspect more in depth the study on WSI classi-
fication performance using gray-scaled 224×224 pixel input.
In this study, for the WSI inference, we use a very simple
heuristic: we perform a majority vote from patches prediction
for a given slide. Fig. 5.4 provides a general overview of
some metrics evaluated, where single patches at different
resolution σ (ranging in [300; 1000] µm), by take in account
the dysplasia grade discrimination as a priority. There is
not a clear choice regarding the optimal scale features have
to be extracted. If our goal is to maximize the sensitivity
for the HG class, we should choose 400 µm: inspecting the
HP’s specificity for the same scale, we observe a drop which,
however, is overall tolerable. F1-score gives us a more global
information: indeed, for the HG class, 400 µm is the best
one. However, if we look at average performance on all classes
(avg), focusing on F1-score and balanced accuracy, we can
observe similar performance for 400 µm and 600-800 µm.
It is important to compare the model performance with
the results obtained by human pathologists. Table 5.1 reports
performance comparison for HP, LG and HG classes in terms
of balanced accuracy, sensitivity and specificity. Here, human
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Figure 5.4: WSI inference performance comparison between
different tissue categories at different patches resolutions: sen-
sitivity (a), specificity (b), F1-score (c) and balanced accuracy
BA (d). Red dashed line is the average performance (avg).
pathologist’s average agreement is taken from Denis et al.’s
work [23], evaluated on qualitatively similar data. The dataset
used by Denis et al. is not publicly available, so the comparison
has to be intended as no more than a guideline. As we observe,
the performances in this study is very close to the pathologists’.
In particular, HP classification increases of more than 10% in
accuracy, showing a quite significant improvement in terms of
sensitivity. LG classification improves as well up to 10% in
balanced accuracy, yielding a significant improvement both in
terms of sensitivity and specificity. HG classification score is in
the same order than human pathologists (this finding is likely
to be due to HG features that are known to be visually easier
to detect).
Fig. 5.5 shows some example of the ANN focus on different
tissue inputs. Our pathologists agree that the highlighted fea-
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Table 5.1: Human hyperplastic and dysplasia diagnostic per-
formance comparison. The original dataset is unavailable for
accurate comparison, but the samples are qualitatively com-




Our (400 µm) 0.90 0.80 0.99
Our (600 µm) 0.92 0.85 0.99
Pathologist [23] 0.79 0.30 0.97
LG
Our (400 µm) 0.76 0.73 0.78
Our (600 µm) 0.71 0.83 0.59
Pathologist [23] 0.66 0.57 0.69
HG
Our (400 µm) 0.83 0.78 0.88
Our (600 µm) 0.70 0.46 0.93
Pathologist [23] 0.83 0.81 0.84
tures are significant for the type of tissue. Fig. 5.6 report some
example of RoIs class inference from the patches prediction.
(a) NORM (b) HP
(c) LG (d) HG
Figure 5.5: Regions where the trained neural network model
focuses on 600µm patches. Above images are obtained with
Grad-CAM algorithm [74]. For example, the hot spot of the
HP sample is on a serrated gland which is a characteristic
features. Instead, in the HG sample, the focus is correctly
placed on the pre-neoplastic lesion.
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(a) NORM (b) HP
(c) LG (d) HG
Figure 5.6: Visualizing patch classification: Each box is lo-
cated at the center of the corresponding patch with a color
representing the predicted class: HP (red), NORM (white),
LG (green), HG (blue). The black dashed square visually rep-
resents the patch scale, (in this case σ = 600µm). Lighter
regions are the annotated area of interest.
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By increasing the number of slides at our disposal, we were able
to investigate classification based on the patches approach in
two different directions.
• approaching classification of full resolution images:
given the µm/pixel ratio with which we know a slide is
produced, patches are generated with the corresponding
size, in pixels, with respect to the chosen σ measure.
• approaching classification by exploring patches with
much higher σ sizes. The number of collected annota-
tions, from which UniToPatho is derived, is sufficient
to adopt “data-greedy” deep learning algorithms. Given
the large size, the minimum number of images will be
at least the number of annotations.
Below the results reported by these analyses and the related
images are taken from our proposed work [1].
We perform our preliminary experiments on the Uni-
ToPatho dataset: this time, in order to expand Perlo et. al [5]
that focus on dysplasia grade prediction, we focus first on the
colorectal polyp type analysis. Thanks to the data collection
for DeepHealth use-case advancement, we can investigate
more methods and strategies in order to achieve better
prediction results. The method which will be described in
the next section builds upon the lessons learned during these
experiments.
In Fig. 5.7 we report the same study performed previously,
by making two important additions to the analysis:
• first we explore way wider resolution. In order to main-
tain a consistent overall number of patches even with
high-resolution clippings, we set a lower-bound on the
number of patches P :
|P (s)| ≤ |RoI(s)|∀s ∈ S (5.2)
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where S is the whole slide collection. We are now going
extend the explored range form σ ∈ [300, 1000]µm range
to σ ∈ [100, 8000]µm range. We repeat the whole train-
ing process for each one of the chosen σ. For each σ,
the trained network is eventually tested on the patches
extracted at the same scale from the test slides.
• we include our PSP regularization method, that is de-
scribed in Sec. 3.2.1. How we described before, we want
to investigate on PSP capabilities in a real-world task.
In order to obtain the results, we randomly color-jitter
the patches described in the previous Sec. 4.4 to augment the
dataset, as proposed in [92, 47]. As in [47, 92, 5], we train a
deep convolutional neural network for image classification on
the patches belonging to the train slides. Namely, we train
an ImageNet-pretrained ResNet-18 [35] with SGD optimizer
for 50 epochs, with an initial learning rate of 0.01 decayed by
a factor of 0.1 every 20 epochs. Furthermore, we decide to
change the dataset balancing policy. By strictly working with
UnitoPatho collection, more experimental trainings show how
including the overlap between patches (as described in Sec. 5.1)
can lead to overfit models (Sec. 3.1). Our conclusion is that the
model learns to recognise the shared tissue patterns in the im-
ages, rather than finding significant tissue features. Therefore,
in the following experiments, we change the dataset balance
policy by duplicating or by removing tissue images from the
dataset pool, in order to have the same amount of images for
each tissue class.
The output layer is reshaped to match the UniToPatho 6-
class classification problem. Each patch is downsampled to the
standard 224×224 pixels ImageNet size prior being fed into the
ResNet.
In the following, the classification accuracy will be defined
in terms of Balanced Accuracy (BA) to cope with the unbal-
anced samples in the dataset. By looking Fig. 5.7, we can get
different conclusions:
• There isn’t an absolute physical resolution that helps us
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Figure 5.7: Classification performance at patches level. The
source dataset was UniToPatho. The dataset is divided into
patches by following the same criterion for different physical
resolutions. (a) shows the BA for the 6 class classification
problem; (b) shows the BA for the polyps type prediction only
(HP,NORM,TA,TVA).
to achieve the best patch classification performance. On
the other hand, we can see how overall performances, on
the 6 classes Fig. 5.7a, start to decrease by going forward
with bigger σ.
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• PSP regularization gives the best results in most of the
σ we take in consideration. This experiment shows its
applicability to our custom dataset.
• Also for the 4 classes polyps classification problem,
Fig. 5.7b doesn’t show a clear indication on witch σ
fits our performance needs. In this graph only, we can
see how the gray scale preprocessing method seems to
achieve generally better results.
We need to delve further into the analysis, though, because
using only global balance accuracy, we may have missed the
behavior of the trained network with respect to the individ-
ual polyp’s classes in the problem. Nonetheless, we conjecture
that different polyp types can be better recognized at differ-
ent scales: as a consequence, in Tab. 5.2 we also show the BA
concerning the classification of each single polyp type HP, TA,
TVA plus NORM. The TA and TVA classes encompass the
respective low grade (LG) and high grade (HG) subclasses. In
Tab. 5.2 (first row) we show the BA achieved when attempt-
ing to discriminate all 6 classes with the baseline approach as
function of the patch scale σ: it can be noted that even the
best accuracy achieved at σ=1500 is quite low.
Fig. 5.8 help us to visualize such behavior:
• Breaking down the accuracy on a per-class basis reveals
that different types of polyps achieve top-classification
accuracy at different scales.
• σ ∈ [800, 1200]µm scale is the best resolution in order to
catch Hyperplastic Polyps (HP) tissues. We hypothesize
these types of benign polyps are best discriminated by
looking at smaller-scale details such as gland edges [85].
• Conversely, Tubular Adenomas (TA) and Tubulo-Villous
Adenomas (TVA) are best classified at a coarser 7000µm
scale: we hypothesize this type of polyps is best discrim-
inated by looking at large-scale macro structures such as
entire glands shapes [89].
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Figure 5.8: Focus Per class, on classification performance at
different patches level. (a) shows the BA achieved on 6 classes
by using raw RGB images; (b) shows the BA for the polyps
type prediction only.
• RGB image prediction performances drop at 7000µm
scale only involves HP class mainly that is misinter-
pret as Normal tissue. Grayscale images model seems
someway overcoming this issue, but, talking about not-
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Patch scale σ [µm]
Type 100 800 1500 4000 7000 8000
BA (6-class) 0.40 0.45 0.46 0.41 0.37 0.38
NORM 0.70 0.66 0.72 0.76 0.78 0.71
HP 0.81 0.92 0.85 0.70 0.60 0.69
TA (HG+LG) 0.65 0.66 0.65 0.71 0.76 0.70
TVA (HG+LG) 0.64 0.67 0.68 0.74 0.84 0.76
Table 5.2: Overall BA for all of the six classes (first row) and
BA for each polyp type, plus normal tissue.
adenoma tissues (NORM and HP), the two downsam-
pled input types have very similar tissue structures.
Coming to the problem of predicting the grade (LG or HG)
of TA and TVA adenomas, we investigate whether that could
be best predicted at some particular scale σ. From our ex-
periments, the adenoma grade classification accuracy does not
appear being a function of the patch scale. In fact, visual in-
spection of the 224×224 pixels downsampled patches reveals
that the downsampling trashes discriminatory details in the
cells nuclei upon which pathologists are known to rely.
Concluding, our preliminary experiments show that i) dif-
ferent polyp types are best classified at different scales (in our
case σ = 800 for HP and σ = 7000 for TA and TVA) and ii)
adenoma grade prediction may be jeopardized if the details
in cells nuclei are lost. The general improvement in accuracy
compared to the 6-class classification across all of the patch
sizes also hints that the grade prediction might be negatively
influenced by the image downsampling.
5.2.1 Inference by ensembling classifiers
This section details our proposed approach towards classifi-
cation of UniToPatho images: a multi-resolution ensemble of
cascaded classifiers. The experiments in Sec. 5.2 showed that:
i) 800µm patches should be used for HP detection; ii) 7000µm
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Figure 5.9: The proposed multi-resolution ensemble of cas-
caded classifiers. The Hyperplastic and Adenoma classifiers
(yellow) are trained with inputs downsampled to 224×224 pix-
els, while the Dysplasia classifier (green) uses full resolution
images.
patches for adenomas detection and classification; iii) grade
prediction might be negatively influenced by the input im-
age downsampling. The proposed main idea is to search for
specific features detected at different σ, by develop a multi-
resolution approach. The method presented in our work Bar-
bano et. al [1] relies on three cascaded ResNet-18 classifiers,
having the output layer specifically adapted for each classifi-
cation task. The classifiers are trained on patches extracted at
either σ = 800 or σ = 7000.
The overall process of inference is depicted in Fig. 5.9, with
the input being a single 7000×7000µm patch which is used by
the three ResNet-18 classifiers mentioned above. For classi-
fiers working at σ = 800, we crop the input image into smaller
800×800µm sub-patches which are used to generate a predic-
tion for the entire image. The ensemble works with 7000µm
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input patches, as it is the largest chosen size among HP, TA
and TVA. The ordering of the different classifiers in the en-
semble follows the accuracy shown in Tab. 5.2: HP detection,
followed by TA and TVA classification. Obviously, grade pre-
diction must be posterior to TA and TVA classification, as it
can only be applied on adenomatous tissue.
HP polyps detection
Starting from a full-resolution 7000µm input image, we first
apply a binary HP classifier on sub-patches of size 800µm ex-
tracted from the input image. First, HP polyps are discrimi-
nated from adenomas and normal images via a binary classifier
that takes as input sub-patches of size 800×800µm extracted
from the larger input image. In fact, Tab. 5.2 shows that
HP polyps are identified with top accuracy (0.92 BA) at scale
σ = 800.
To infer the probability of predicting HP for entire im-
age, we compute the average predicted probability of the sub-
patches of being HP. In the case the patch content is not clas-
sified as an HP polyp, the second classifier in the cascade is
invoked.
Adenoma detection
Second, TA adenomas are discriminated from TVA adenomas
and from normal images via a ternary classifier taking as input
the entire 7000×7000µm patch. In the case the patch content
is classified as a TA or TVA polyp, the third and last classifier
is invoked to infer its grade. Tab. 5.2 shows that TA and TVA
adenomas are identified with top accuracy at this scale. To
accomplish this, we define a “super” class OTHER by grouping
NORM and HP. Therefore, e train a classifier on the classes
OTHER, TA and TVA. This approach can easily be extended
to include other tissue types by adding samples to the OTHER
class, without changing the network architecture. Given that,
in this case, the classifier is applied to negative HP-predicted
samples only, images which are not classified as either TA or
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TVA are labeled as normal (NORM). Thus, employing the
super class OTHER, also easily allows for different ensemble
hierarchies.
Dysplasia grade classification
Finally, a binary classifier is used to determine the dysplasia
grade for TA and TVA adenomas. Sec. 5.2 suggested that
downsampling the patches to 224×224 pixels might be detri-
mental towards inferring the dysplasia grade due to the loss of
important features such as cells nuclei, as also observed by [80].
Thus, only for this specific classification task, we skip down-
sampling to prevent the loss of fine grained details. The dys-
plasia classifier input are full resolution tissue patches, so the
patch edge measures 800× 0.4415µm/pixel = 1812 pixels. To
account for the increased size of the feature space, we add an
adaptive average pooling layer [36, 95] before the fully con-
nected layer of the ResNet-18 network. We repeat the experi-
ment of Sec. 5.2 sweeping the patch scale σ this time without
downsampling and we find that adenoma grade classification
peaks (0.81 BA) for σ = 800. As a consequence, we apply the
grade classifier on sub-patches extracted from the input image
at the scale σ = 800. Finally, we infer the dysplasia grade for
the entire input image according to a threshold Td: if the ratio
of high grade predictions on the sub-patches is higher than Td,
the image is labeled as HG, otherwise as LG. This choice is mo-
tivated by pathologists grading guidelines, where HG can be
decided on the base of small portions of tissue; clearly, setting
smaller values for Td can mimic this behaviour [88].
5.2.2 Evaluation by
multi-resolution ensemble
We evaluated a multi-resolution classifier ensemble on the
7000×7000µm test patches of UniToPatho on top of the
previous analysis. By analyzing different Td threshold effects
on the ROC curve displayed in Fig. 5.10, we tune the classifier
responsible for the dysplasia grade prediction. As expected,
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the Td allows one to reach a good compromise between true
and false positive rates yielding a good AUC score of 0.83. In
















Figure 5.10: ROC curve for the adenoma grade predictor as a
function of the threshold Td.
the experiments reported below, we choose to use Td = 0.2,
as it strikes a favorable balance between false positives and
sensitivity score. In which cases where minimizing the false
negatives rate is more important, for example in clinical
applications, lower thresholds may be preferred.
Fig. 5.11 shows the 6-class confusion matrix of the proposed
method compared to the baseline approach described in Sec.
5.2. Looking at the diagonal, it is quite evident that the pro-
posed method significantly improves in average accuracy, that
leaps from 0.46 to 0.67 (50% relative increase). The baseline
reference is taken by using σ = 1500 which, as already shown
in 5.7, yields the best overall BA.
The multi-resolution approach shows remarkable improve-
ments in assessing the correct grade. On the other hand, we no-
ticed previously how the baseline model is biased towards the
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(a) Baseline
















86% 14% 0% 0% 0% 0%
18% 79% 0% 4% 0% 0%
10% 2% 60% 15% 5% 8%
3% 22% 14% 50% 3% 9%
0% 0% 5% 0% 78% 16%
15% 11% 0% 7% 15% 52%
(b) Multi-resolution Ensemble
Figure 5.11: Confusion matrices for the (a) baseline at
σ = 1500 (b) multi-resolution ensemble.
lower grade classes: this represents further proof that down-
sampling the images results in the lack of useful features to
distinguish high grade from lower grade and normal tissue.
Tab. 5.3 reports other metrics that are common in the re-
lated literature. The multi-resolution approach achieves quite
high specificity for all classes, and we can claim, especially for
the higher-risk TA.HG and TVA.HG classes, promising sensi-
tivity values.
Finally, we also analyze the per-type performance, as done
in Sec. 5.2. The results are shown Tab. 5.4. Notably, there is
a great reduction in false positive adenoma predictions, and,
most importantly, a more precise distinction between Tubular
and Tubulo-Villous adenomas. Despite the small HP class ac-
curacy drop we observe an increase for all of the other tissue
classes.
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HP NORM TA TVA
HG LG HG LG
Sensitivity 0.86 0.79 0.60 0.50 0.78 0.52
Specificity 0.93 0.87 0.92 0.94 0.96 0.92
Positive Discovery
Rate 0.43 0.44 0.85 0.60 0.76 0.44
Negative Predictive
Value 0.99 0.97 0.73 0.92 0.96 0.94
False Positive Rate 0.07 0.13 0.06 0.08 0.04 0.08
False Negative Rate 0.14 0.21 0.50 0.40 0.22 0.48
False Discovery Rate 0.57 0.56 0.15 0.40 0.24 0.56
Accuracy 0.93 0.86 0.87 0.76 0.93 0.88
Balanced Accuracy 0.89 0.83 0.76 0.72 0.87 0.72
F1 Score 0.57 0.56 0.63 0.60 0.77 0.47
Table 5.3: Sensitivity, Specificity, BA and other common met-
rics per class: Balanced Accuracy, Sensitivity and Specificity
levels are qualitatively comparable to the pathologists agree-
ment [23]. Despite medium sensitivity values for LG adeno-
mas, specificity values are stable for each class.
σ HP NORM TA TVA
Baseline 800 0.92 0.66 0.66 0.67
Baseline 1500 0.85 0.72 0.65 0.68
Baseline 7000 0.60 0.78 0.76 0.84
Multi-resolution - 0.89 0.83 0.81 0.87
Table 5.4: Comparison of the class BA between the baseline





In this chapter we present another case study, which is com-
pletely different from what we’ve seen above. In this study the
subject of analysis changes and the focus is on the analysis of
images of the brain. Specifically, we describe our experimental
contribution by collecting and analyzing Computed Tomog-
raphy (CT) scans of the brain, with the goal of identifying
cerebral vessel occlusions in ischemic stroke cases. This study
has been included as a use-case in DeepHealth project, and
the collected images are composing a new dataset, named as
UniToBrain[3], within the perimeter of the project.
6.1 Overview
The occlusion of a cerebral vessel causes a sudden decrease in
blood flow in the surrounding vascular territory, in comparison
to its centre. The identification of such an occlusion reliably,
quickly and accurately is crucial in many emergency scenarios
like ischemic strokes [26]. The CT perfusion (CTP) is a medical
exam for measuring the passage of a bolus of contrast solution
through the brain on a pixel-by-pixel basis. CT perfusion is
performed with a sampling time of approximately 1 Hz. Based
on these measurements, low-dose serial scans are acquired and
blood time-density curves, corresponding to the passage of the
75
CHAPTER 6. PERFUSION BRAIN MAPS PREDICTION
contrast agent into the brain tissue, and several other paramet-
ric maps are calculated. The most relevant parameters used
in clinical practice are maps representing cerebral blood vol-
ume, cerebral blood flow and time to peak (called CBF, CBV,
TTP respectively) [7]. In particular, ischemic lesions develop
very rapidly, originating from the central area of the occluded
vascular region and progressively expanding to increasingly pe-
ripheral regions. From the onset of symptoms, two different
regions can be identified in the problematic ischemic area of
the brain: a central “core”, corresponding to the area of irre-
versible damage, and a peripheral “penumbra”, corresponding
to the area of potential recovery and possible recanalization,
provided by the occluded vessel, are visible. Generally, CBV
maps are used for core segmentation, while CBF and TTP for
penumbra areas. Therefore, the identification of the core and
of the penumbra can predict the fate of the brain tissue itself
and guide physicians in reperfusion treatments [26, 91]. An
example of colored perfusion maps and core-penumbra region
is shown in Fig 6.1. The extent of the core and its penum-
bra area can be estimated clinically based on symptoms and
their time of onset, and using common perfusion techniques
such as CTP. A time-intensity curve is the result of process-
ing the signal intensity values over time. Several algorithms
are used to perform deconvolution of time-intensity curves,
but some of them are not public and may produce maps with
divergences [50]. If we place ourselves in an ideal environ-
ment, where we find limited noise, limited variance and no
artifacts created by patient motion during scanning, the opti-
mal choice for obtaining realistic, accessible and reproducible
maps is an analysis performed pixel by pixel, such as the one
performed by deconvolution-based algorithms. Unfortunately,
in the real clinical case, the information must be redundant
in order to overcome the problems caused by the presence of
noise, large variances and motion artifacts. In practice, this
results in obtaining more brain slices, requiring more patient
X-ray exposition, more acquisitions, estimation of an Arterial
Input Function (AIF), and a series of spatial pre-processing
steps for noise and variance reduction. The following method
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Figure 6.1: Examples of perfusion maps, in which the core
is highlighted by the black arrow in the CBV map (top-right
image) and the penumbra is is indicated by white arrows in
CBF and TTP maps. The image is taken from Gava et al. [30]
and more detailed results are presented in Gava et al. [30].
6.2 Data collection
The Neuroradiology Division in Molinette Hospital, Turin
(Italy), collected perfusion data from 127 patients, retrieving
them from the hospital’s PACS system retrospectively. The
CTP acquisitions were performed using a GE 64 Scanner, and
the parameters for the examination were defined as follows,
the same for each case: 80 kV, 150 mAs, 44.5 sec duration,
89 volumes (40 mm axial coverage), injection of iodinated
contrast agent for 40 ml (300 mg/ml) at 4 ml/s speed.
Perfusion maps, including CBF, CBV, TTP, were calculated
using a standard spatial pre-processing pipeline followed by a
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nonlinear regression (NLR) method based on a state-of-the-art
fast model developed and described by Bennink et al. [10]. A
motion correction is required and was performed using a rigid
registration method. Next, all images were pre-processed by
implementing a bilateral filter [46]. Estimates of the AIF and
vein output function (VOF) were made automatically using a
sample of 100 voxels. The impulse response function (IRF)
of perfused tissue is described by the model developed by
Bennink et al., in terms of CBV and tracer delay, which is
fundamental in the clinical context of ischemic stroke. The
tissue temporal attenuation curve and associated maps (CBV,
CBF, and TTP) are then estimated using the AIF and IRF
calculated by that method [10].
In this collection, 12 of the total cases under analysis were
excluded due to unreliable data: no contrast seen, excess of
motion, or premature termination of the acquisition procedure.
The remaining 115 were divided into a subset of 100 patients,
for AI training described later, and 15 to validate the results
and the performances.
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6.3 Study and method
Employing Deep Learning approaches to the problem of
deconvolving time-intensity curves, offers several potential
advantages over canonical algorithms. Indeed, DL allows the
extraction of information and features that are relatively in-
sensitive to noise, misalignments and variance. Gava et al.[30]
shows whether a properly trained Convolutional Neural
Network (CNN), based on a U-Net-like structure, on a
pre-processed dataset of CTP images, can generate clinically
relevant parametric maps of CBV, CBF and time to peak
TTP.
Since this specific model has been originally thought for
medical images segmentation [67], and in this case the goal is
to generate parametric images, some changes to the standard
model are introduced. There is evidence that this CNN model
is effective in other tasks, other than image segmentation, as
well [29]. In contrast to similar state-of-the-art U-Net based
methods, no extra information, like the above mentioned ar-
terial input function AIF, has not been provided to the U-Net
model.
We provide a short description on how to train an ANN
model by using perfusion CT scans to generate CBV, CBF,
and TTP maps. The raw inputs are a collection of multiple
CT scans and 8 target CBV, CBF, and TTP maps for each
patient, in DICOM format. DICOM format is an acronym for
Digital Imaging and Communications in Medicine and it is the
standard for the communication and management of medical
imaging information and related metadata. Each target map
corresponds to the output of the perfusion scan at a certain
scan height of the patient’s brain. Thus, given a target t gen-
erated at a specific height h for a patient p, we need to search
between his CT scans for all images ip (in grayscale format)
acquired at the same height h. In our case |iph| = 89, ∀t
p
h: the
same brain portion appears 89 times at different scan timing.
The input pre-processing consists in finding the images corre-
lated by h and grouping them in a single image tensor, whose
depth is equal to 89, for each th. Fig. 6.1 summarizes this
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input preprocessing step. Therefore CT images can be viewed
Figure 6.2: A representation of the UniToBrain input pre-
processing step.
as 3D tensors, with the third dimension being the time axis.
The pre-processed images are the only input for the trained
U-Net network architecture [67]. Here, we consider using it for
inference on perfusion maps. The overall model can be found
in Fig. 6.3. We slightly change the original architecture design
Figure 6.3: A representation of the U-Net architecture used to
generate perfusion maps. The model takes as input the scans
acquired in different time instants. The images resolution is
512×512. After four encoding stages, the decoder stages pro-
duce a map with the same input resolution.
due to empirical quality observation of the generated maps:
Max-pooling layers have been replaced by Averaging-pooling
layers. Using the traditional Max-pooling layer here is sub-
optimal, as there isn’t any expectation of sparse feature extrac-
tion. As described in Sec. 2.3, we use a common loss function
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definition for image generation tasks. We minimize the mean
squared error (MSE) loss between the required ground-truth
and the U-Net output. Additional information or data (e.g.
AIF) are not provided to the CNN: all information is found in
the pre-processed input CT images. The model is pre-trained
to produce a 128×128 output map for 250 epochs, after that it
is trained and tuned for 50 epochs to produce 512×512 maps,
in which all pixel values fall into the range [0; 1]. The choice
to pretrain the U-Net model with downsampled images comes
mainly from practical factors. Training on full resolution im-
ages requires a high consumption of GPU memory and the
time needed to reach model convergence becomes very high.
Training on downsampled images allows to reach a solution in
a much shorter time, since the task is simplified. The pretrain-
ing step produces a suitable set of starting parameters for the
model: this type of approach is often used for training genera-
tive networks, and the results are comparable, and smoother,
than those produced with very high dimensional image train-
ing. The training of the entire model is done using the Adam
optimization strategy.
6.4 Results
The following are the results of training the U-Net architec-
ture for the three identified target perfusions, CBV,CBF and
TTP. The evaluation of the resulting images is performed by
the value of the loss Mean Square Error (MSE) function, and a
metric called Intersection over Union(IoU). While MSE clearly
indicates how much the predicted maps deviate from the tar-
get, the IoU metric just indicate how many pixels reach a sig-
nificant activation with respect to the target image. The IoU
have not to be intended to have any medical meaning, because
it takes in account also target meaningless regions for diagno-
sis. IoU is defined as the ratio between the intersection of the
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Eq. 6.1 shows its definition, in witch y is the CNN output and
ŷ the ground truth. Since both y and ŷ values fall in the range
[0; 1], a threshold is set to 0.5 and IoU is evaluated on resulting
binary masks.
Fig. 6.4a shows how IoU increments during the pretrain
phase, while Fig. 6.4b reports that MSE reach promising val-
ues below 0.01. While CBV and TTP experiments show simi-
larities in both measures, CBF reaches lower IoU scores. From
the trends of CBF curves, the map generation seams more
difficult to be learned rather than CBV and TTP. Also MSE
shows a slightest decrease for CBF, that confirm the major
task complexity. Fig. 6.5 show some examples of generated
perfusion maps from the U-Net training. The U-Net CNN can
accurately evaluate the perfusion parameters by only using CT
scans images only, without any other input information. On
the other hand, decomposition-based CT and MRI methods
for analyzing cerebral perfusion require additional input data,
such as AIF curves measured in the saphenous vein. This
suggests that the CNN solution can combine the information
associated with both tissue and arterial signals to estimate
CBV, CBF, and TTP maps. On the other hand, other re-
cent automated analysis methods use AIF to estimate ischemic
core before calculating perfusion parameters [14]. The U-Net
CNN approximates sufficient perfusion mismatch in brain tis-
sues to create an information-rich perfusion map for patients
with ischemic lesions. In addition, the growing potential of
machine-learning-based perfusion analysis methods could lead
to new and improved standards in acquisition protocols and
administered radiation doses.
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(a) Growing IoU metric on the test set during the pretraining phase.
(b) Decreasing MSE metric in the same train configuration. Low is bet-
ter, it indicates that the generated maps are numerically very close to
the targets. MSE does not require image binarization to be evaluated.
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Figure 6.5: Examples of map predictions for each target type.
The image on the left represent the U-Net output, while the





The European Union is spending significant amount of re-
sources properly leading the AI development and research to
maintain its proper position in this emergent and challeng-
ing context. EU funds projects to deploy pilots and large-
scale experimental research solutions by combining the latest
discovered technologies in artificial intelligence. The same ef-
fort is spent to support AI technologies like distributed high-
performance computing, cloud computing and big data sup-
port. DeepHealth, as described in the first chapter, is an
example of this effort, that is thought (and developed) as
health-focused project. The European framework of Deep-
Health, called DeepHealth Toolkit, is a single entity that aim
to use heterogeneous architectures, such as high-performance
computing, big data and cloud computing, to provide deep
learning capabilities and computer vision off-the-shelf services,
that can be easily integrated into any software project and de-
ployed on any computing platform. DeepHealth Toolkit ’s aim
is to make it easier to develop and deploy new applications
that solve specific problems regardless of the type of context
or application field. This chapter mainly describes our ex-
perimental contribution to the DeepHealth Toolkit, by taking
into account some of its main components, in particular EDDL
and ECVL libraries, and performing performance testing and
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comparisons. The performance reports are comprehensive of
model training time, CPU/GPU usage, GPU allocation, mem-
ory allocation, and GPU temperature, by showing multiple dis-
tributed training scenarios. We first present the idea of how
DeepHealth Toolkit is indented to use to facilitate its usage
in the European community by developers and data scientists
working on AI-based solutions in health care and other fields.
A visual representation is shown in Fig. 7.1.
Figure 7.1: DeepHealth Toolkit schema that shows service ex-
changes between all its inner components. This schema is
taken from book chapter dedicated to DeepHealth [4]
The DeepHealth Toolkit is a versatile deep learning system
with fully integrated image processing and computer vision
(VC) capabilities that uses HPC and cloud infrastructure to
perform parallel and decentralized AI inference and learning
processes. Under the MIT license, each component of this EU
instrument is freely available as open source software. The
toolkit is designed to handle large and growing datasets, by
matching the nature of medical image datasets. For those large
datasets, more and more sophisticated neural networks and
learning strategies can be used to improve the accuracy and
reliability of AI-based predictive models, but at the expense of
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much higher computing power requirements. To that end, the
DeepHealth Toolkit solution aims to transparently integrate
the latest parallel programming technologies to leverage the
parallel performance capabilities of HPC and cloud infrastruc-
tures, by including symmetric multiprocessors (SMPs), graph-
ics processing units (GPUs) and various other computing ac-
celeration technologies. It also includes external frameworks to
generalize the toolkit to specialized infrastructures and allow
different levels of parallelization mechanisms. The toolkit also
includes features that can be used for training and inference
by abstracting the complexity of different computational re-
sources and facilitating architecture developments adopted in
the learning and inference phases. AI specialists will train AI
solutions on dedicated HPC architectures equipped with the
latest GPU components. The goal is to maximize the number
of the data samples processed each second, while the overall
accuracy remains stable. The AI inference (or test) phases are
made in a future production environment, by including small
dedicated devices, by using trained models, where the response
time required to predict a single data sample, or image, is
critical. In order to support AI-based application developers,
data scientists, and ML professionals in general, DeepHealth’s
unique toolkit is designed to provide the following targets:
• Increasing the productivity of both data and computer
scientists, by reducing the time required to the train-
ing processes by parallelization on HPC and cloud in-
frastructures, and also providing a tool to speed up the
design and test of predictive solutions in a unique tool.
• Facilitating the development and deployment of AI-
based applications and models, by providing the most
common DL and VC capabilities in a single, integratable
toolkit that supports multiple operating systems. It also
allows DL trainings outside of the application/platform
installed by installing locally those DeepHealth Toolkit
libraries the developer needs.
• Freeing the needs for highly professionals HPC and cloud
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experts. The AI solution learning processes can run
transparently to the data scientist. Therefore, data sci-
entists and developers can work with less in-depth knowl-
edge of HPC, DL, VC, big data or cloud computing.
Furthermore, a production application does not need to
be adapted to running multiple distributed processes on
HPC infrastructures.
A more detailed overview can be found in the publication ded-
icated to DeepHealth [22].
7.1 EDDL
EDDL is a deep learning library that was originally developed
to be general-purpose and meet the AI development needs in-
side the DeepHealth context, therefore with the aim to be
used in healthcare applications. EDDL is a free and open
source software library, available on online repository as a core
part of the DeepHealth Toolkit, as we can see in Fig. 7.1. At
the moment, it integrates and supports the most popular and
well known deep neural network topologies, by including both
convolutional and recurrent models. These models can be
used for a variety of already discussed tasks such classifica-
tion, time series prediction, machine translation, semantic im-
age segmentation, and also image description. EDDL uses the
Open Neural Network eXchange format (ONNX [62]) in order
to interface itself with other DL libraries, enabling the import
and export capabilities of neural networks models, by includ-
ing weights (if already trained) and topology. It is essential
for maintaining compatibility and exchanging solutions with
existing and widely used development tools and other deep
learning tools, like PyTorch or TensorFlow. EDDL aims to
simplify the development of hardware-specific accelerated deep
learning mechanisms by providing hardware-independent ten-
sor operations and ANN topologies components like activation
functions, regularization functions, optimization methods, and
multiple types of different layers. Those components fall into
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two main categories: ANN operations, as models, layers, regu-
larization functions, initializers, and tensor specific operations
like serialization, I/O, and mathematical transformations. The
tensor is the mathematically manipulable data format which
allows to perform all the needed calculation in a DL appli-
cation. The neural network library contains both high-level
tools, such as training and evaluation of a model, and low-level
tools that allow for finer control of each step in the training
or inference loop, like individual epochs, batches, or gradient
manipulation. The core implementation of EDDL is done in
C++ programming language. In order to rise the attractive-
ness of EDDL to the whole scientific community, A Python
application programming interface (API ) has been developed,
with the name PyEDDL. PyEDDL is a Python library that
provides EDDL functionalities and interfaces them to a lot of
popular scientific programming and data manipulation tools,
like NumPy/SciPy and Pandas. In particular, PyEDDL sup-
ports bidirectional conversions between internal EDDL tensors
and NumPy tensors, which is a key integration step to achieve
compatibility with other existing Python libraries. PyEDDL
is born as a native extension of the EDDL by wrapping its
C++ core. It allows users to take advantage of all the ben-
efits of using Python language for development and by using
Python as a high-level abstraction to combine computationally
intensive procedures. Like other elements of the DeepHealth
Toolkit, also PyEDDL is released as free and open source soft-
ware, and the source code is available. Neural network build
functions are already included in PyEDDL/EDDL framework.
These functions create all needed data structures, based on
the network topology itself, and allocate the necessary mem-
ory. Via these build functions, it is possible to describe the
available hardware that EDDL will use to perform the train-
ing and other processing. Each hardware description is called
Computing Service. At the moment, there are three types of
computing services defined: CPU, GPU, and FPGA. compu-
tational services. EDDL GPU support is provided by a specific
CUDA kernel developed as a component of the EDDL core. As
mentioned earlier, the use of different hardware and architec-
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ture wants to be completely transparent to AI developers and
programmers. By simply creating the appropriate Computing
service to use all or a fraction of the available computing re-
sources. The DeepHealth Toolkit also provides the computing
GPU acceleration NVIDIA cuDNN library as integration into
EDDL as an alternative to the native CUDA kernel.
EDDL represents internally the topology of a neural net-
work by two different directed acyclic graphs DAGs, for for-
ward and backward training stages. Each DAG represents the
sequence of mathematical operations to be performed on ten-
sors, in order to make the computation described in the net-
work model definition. Each layer computation is done when
all dependencies for that level are satisfied, according to the
DAG. Therefore a layer computation is performed when all the
computation for its inputs are done. By working on GPUs,
EDDL has three memory management modes to manage pos-
sible memory shortages. It helps EDDL to scale over different
hardware components. In the most performing mode, EDDL
tries to minimize as possible the number of memory trans-
fers by allocating the most of the graph tensors to the GPU
memory. On the other hand, less efficient modes handle larger
graphs by increasing the number of memory transfers for for-
ward and backward stages. In distributed learning in HPC and
cloud architectures, EDDL includes special features to simplify
the batch distribution for training and inference processing by
using well known HPC frameworks. Those frameworks’ pur-
pose is to accelerate DL learning by partitioning the training
dataset into a large number of compute nodes to perform par-
tial learning processes. EDDL uses ONNX to serialize the
network and manage weights and gradient transfers between
a master node and worker nodes. In order to meet different
needs in distributed learning applications, the serialization fea-
ture implemented in EDDL allows the user to choose whether
to include weights or gradients. The PyEDDL/EDDL code is
tested by a full test suite, by covering a number of use cases
in Python and C++, by including various models training and
evaluating scripts, ONNX serialization, NumPy compatibil-
ity, etc. PyEDDL/EDDL provide the documentation and ex-
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amples in order to facilitate the library installation and the
applications’ development.
7.2 ECVL
The European Computer Vision Library (ECVL) is the
DeepHealth computer vision library, developed to be general-
purpose, with a special focus on supporting healthcare appli-
cations. ECVL goal is to facilitate the integration between
applications and existing libraries, such as OpenCV [61]. It
provides high-level computer vision capabilities, by providing
also specialized and hardware accelerated implementations of
commonly used image processing algorithms in deep learning.
Of course, these capabilities are useful for image processing
in other application areas and contexts other than strictly
in healthcare. ECVL is designed to provide its services on
top of a Hardware Abstraction Layer (HAL). HAL allows,
while maintaining the same interface, to maintain a flexi-
ble differentiation of hardware for accelerated features. The
hardware-independent API simplifies the libraries usage of and
facilitates the development of image processing components
in distributed and parallel computing environments. ECVL’s
design revolves around the pivotal concept of Image as the
centerpiece of the entire library. ECVL gives support to many
scientific image data types and file formats, like jpeg, png,
bpm, ppm, pgm. Special features are included in the library
for medical image data manipulation. These images are often
retrieved with proprietary or multi-scan formats, such as
DICOM, NIfTI and others virtual slide formats. In some of
these complex image formats, the Image object representation
allows to highlight a specific area and magnification, in order
to extract the interested image portion from the file. Image
component is designed to capture and process a wide range of
different types of images. A main feature is the capacity to
work across different image channel configurations, by provid-
ing read and write operations for all the already mentioned
data formats. Image provides the arithmetic instruments
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in order to apply mathematical operations between images
and scalars. More common affine image transformations,
such as rotating, scaling, mirroring, and color space changes
are available. ECVL image transformations implementations
are designed to run during training of deep neural networks
as data augmentation technique support. ECVL provides a
simple domain-specific language (DSL) [15] in order to extend
the definition of applicable transformations and their input
parameters. This allows customization of sets of options to
be defined for each data subset, like training, validation, and
test. Additional modules are included in the library and,
when enabled, provide additional functionality, such as the 3D
Volume Viewer, which allows users to easily visualize images
of ECVL imaging objects and view different CT slices from
different angles. ECVL defines DeepHealth Dataset Format
(DDF) as a simple mechanism for describing an image dataset
that will be used in training distributed models. DDF consists
of a YAML-based syntax document: a DDF file contains all
the information needed for dataset characterization, data
loading, image pre and post-processing. In addition, special
Dataset modules for reading and parsing DDF files have been
implemented and are available through the library interface.
ECVL is accompanied by a Python API called PyECVL, just
like PyEDDL/EDDL, whose main advantage is that it not
only speed up application developments but also integrates
with the rich Python ecosystem of scientific of programming
tools. PyECVL is also based on a wrapper that redirects calls
to the C++ code, allowing users to take advantage of Python
development without sacrificing performance. PyECVL
provides all ECVL services, including Image objects, different
data types and colors spaces, mathematical operations, image
processing, input/output functions and DDF parser extension.
As already said, support for NumPy allows developers to
process data with many other scientific tools. ECVL born to
support the use of GPUs to run the computer vision algo-
rithms needed for Deep Learning. The GPU implementation
also uses CUDA kernels and this makes the AI solutions
more power-efficient and cost-effective. PyECVL/ECVL, as
92
CHAPTER 7. DEEPHEALTH EUROPEAN LIBRARIES
well as other toolkits, are available as open-source software.
Each release includes documentation, extensive testing suites,
and several use cases with both interfaces. Examples include
DeepHealth dataset manipulation, EDDL/PyEDDL handling,
image processing, and I/O. Therefore, the documentation
includes detailed instructions for installing each library
independently.
7.3 Comparison with PyTorch
In this section we want to try to give an idea of comparison
of performance and DL application development paradigms
between the EDDL/ECVL libraries and the widely used Py-
Torch. The comparison is made, specifically, using the Deep-
Health Toolkit with the respective Python portings, PyEDDL
and PyECVL. First, we want to give an overview of differ-
ences in AI application development paradigms between the
AI Python engines. After, we set up multiple run configu-
rations, for both the use cases seen before, in order to show
and discuss performance benchmark results. We perform all
the simulations on the HPC4AI [8] infrastructure. HPC4AI
is a federated cloud platform for high performance computing
developed by University of Turin, in collaboration with other
local institutes, that support the AI application development
and distribution for research and industries. We use a remote
container manager, called Kubernetes, in order to access the
HPC4AI computational resources. All the distributed learning
setups are made by accessing the same resource instance that
consists of four 16 GB NVIDIA GPUs Tesla T4 and CUDNN
support.
AI model definition
Starting from the definition of the AI model, the architecture
is defined PyEDDL as a concatenation of layers that evolves
from a basic entity defined as eddl.Input , also belonging to the
EDDL definition of Layer. Every subsequent operation, that is
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every additional layer of the model, is defined taking a previ-
ously defined Layer entity as input. Basically, a neural network
architecture is represented as a Layers chain. Also weight ini-
tialization algorithms are defined as Layers in the chain. Here
we notice the first difference in the paradigm of development in
EDDL and the paradigm used by PyTorch. In the latter, the
model is a set of Layer components, while the chain of actions
is defined separately in a forward function. This combines the
outputs of the defined layers, not the layers themselves, di-
rectly from a more generic input tensor. The different design
choice for PyEDDL comes from the ability of the EDDL engine
to calculate the dimensionality of the tensors involved at each
step of the chain in a transparent way. This leads to simpli-
fication in the development of architectures, since, differently
from the PyTorch engine, the developer has to worry about the
correct dimensioning of the tensors. The interchange of archi-
tecture definitions between the two development paradigms is
possible through the ONNX tool, which defines a common and
standard encoding.
The definition of AI Model in EDDL is not limited to its ar-
chitecture. In EDDL, a model is thought of as the whole chain
of layers plus the “building” of necessary components to train
the architecture. Consequently, the whole model includes the
definition of the optimization algorithm, e.g. SGD or Adam,
the declaration of the loss function, an evaluation metric, and
most important the definition of the hardware on which to
train the model. This last component is necessary to define
the abstraction level for distributed computing described in
the previous section.
Dataset management
PyTorch exposes the generic primitives necessary and expand-
able for dataset handling, be it image data, tensors, audio or
other formats. Unlike PyTorch, PyEDDL and EDDL do not
have proper internal dataset handling. The dataset manage-
ment is delegated to PyECVL/ECVL, which uses the descrip-
tion of the data in the DeepHealth Dataset Format, already
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described in Sec. 7.2. Since ECVL is a library dedicated to
computer vision, it is not possible, at the moment, to use the
PyECVL API to work with different data formats. For exam-
ple, the UniToBrain use case uses gray-scale images only for
the target maps, while the input images are stacked in tensors
with high depth as single input. In addition, at present time,
the management options for the image dataset itself are still
limited. There are no native APIs that allow balancing and
sampling options, which are features present in other widely
used libraries.
Of course it is possible to describe the dataset in the Deep-
Health Dataset Format, but at the moment the API provided
does not allow handling non standard data format. In our
opinion, this is a current limitation that weakens the incen-
tive to use the DDF. It must be said that EDDL/ECVL are
now in their first official release, so there will surely be room
for expansion to embrace the needs of AI applications in more
complex contexts.
Data augmentation
As with dataset management, data augmentation options are
delegated to ECVL. As we saw in Sect. 3.1, data augmenta-
tion is a very effective regularization technique to avoid overfit
of neural network-based AI models, as they present “variants”
of the input images to improve generalization. These tech-
niques are widely used especially in case of poor and unbal-
anced datasets. Currently, ECVL does not expose a high sup-
ply of effective data augmentation techniques. For example,
unlike PyTorch, many useful transformation functions, such
as color jittering, saturation, solarization and hue adjustment,
are not yet available. Above all, the ability to define a cus-
tom image transformation function in the data augmentation
pipeline, equivalent to PyTorch’s tranforms.Lambda , is missing.
These gaps will surely be filled in the future by ECVL
developers in the future releases, so as to encourage the usage
of European libraries for AI applications without having to
worry about losing in capabilities and expressiveness.
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Training and inference loops
If we compare the construction of the training loops in the
two libraries, EDDL tries to offer more primitives for training
management at different abstraction levels. PyTorch offers a
unique set of APIs for a low level management of all the steps
of the training loop: choice of the data batch, the model predic-
tion step, followed by the calculation of the loss function, the
optimization step, update of the neural network weights and
eventually the learning rate management step, called Sched-
uler. This low level management is also offered by EDDL, to
which are added also more generic APIs that come to group all
these elements. Certainly, for more complex or peculiar tasks,
their usage is not recommended, as the training loop is used
as a black-box, limiting the control on it. In its first release,
EDDL is still missing some important management options,
like the PyTorch Scheduler, in order to offer a complete set of
tools to replicate the current state-of-the-art DL applications.
Some of these features will be added in the future to spread
EDDL usage.
Distributed training
EDDL has been designed to simplify the use of distributed
learning. Distributed learning identifies the possibility to split
the computation on multiple dedicated hardware, accelerating,
in the case of AI applications, the training time. Distributed
learning requires that copies of the trained model be deployed
on different hardware, such as multiple GPUs, and that the
data to be split between them. During the optimization step,
parameter updates are averaged over the results of each copy,
and all copies are updated equally. This feature is essential
to achieve high performance in high-performance computing
environments, taking advantage of the full resource capacity
provided. Setting up distributed training with EDDL is very
simple. During the “building” phase of the model, already
mentioned above, it is possible to indicate the references to the
hardware resources, or devices, to be used and the frequency
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of synchronization of the copies of the model. The training
is so distributed, in a completely transparent way to the de-
veloper. EDDL internally takes into account the devices used
and synchronizes data between them. Compared to a widely
used solution like PyTorch, this is a remarkable simplification.
PyTorch requires, in a distributed computation application,
wrappers for the dataset and the model, as well as a man-
ual (and error prone) management of the processes and their
concurrency for each GPU.
7.3.1 Evaluation on UniToPatho
In this section, our purpose is to evaluate how much the Eu-
ropean libraries can be considered competitive, at the current
state of development, with respect to the tool that currently
dominates the landscape in the development of DL applica-
tions. We evaluated the different implementations, in Py-
Torch and in EDDL on HPC4AI environment, by accessing
exclusively to 4 NVIDIA GPUs, and we use distributed train-
ing to compare the libraries. In this subsection we are going
to compare the performances by reproducing the training of
one of the necessary components of the inference pipeline on
histo-pathological images, previously presented in Sec. 5.2.1.
In particular, the training of the intermediate classifier, dedi-
cated to the detection of adenomas, is proposed [1]. The train-
ing is carried out for a total of 100 epochs using the images
available in UniToPatho at 7000×7000µm resolution resized
to 2224×22424 pixels. For each simulation we used the same
parametrization: we use the SGD optimizer applying a learn-
ing rate of 1e−4, momentum equals to 0.99, and weight decay
set to 5e−4. In order to have a fair comparison, we use just the
image augmentation proposed in both libraries: image flipping
on both vertical and horizontal axis, random rotation, contrast
and brightness adjustment. Other image augmentation, such
as saturation, solarization and hue adjustment have been omit-
ted.
We experimented and benchmarked how the two libraries
perform during distributed training with dedicated hardware.
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The trainings, are performed in different setups: 1, 2 or 4
dedicated GPUs. For each training, we increase the batch size
accordingly with the number of GPUs, in order to have the
same amount of data sent to each GPU across all the runs.
In these experiments we use a batch size of 32,64 and 128
respectively.
(a) (b)
Figure 7.2: Performance summary on different use case setups.
It is possible to see how the convergence of the model to the
solution is caught up for every proposed setup. EDDL runs
are highlighted in purple, orange and yellow, while PyTorch
runs are in the blue to green range color.
Fig. 7.2 shows that each implementation can converge to a
solution, which have similar prediction performances for each
distributed training setup. Fig. 7.2a shows dissimilarity in
reaching low error values during the training phase. This be-
haviour comes from the different policy used by EDDL and
PyTorch to synchronize the training model across multiple
GPU. EDDL synchronization is done by averaging the model’s
weights after each iteration, so the overall model is the average
of each GPU-local set of weights. Instead, PyTorch synchro-
nization is designed to average the computed gradients for each
iteration, and then update each GPU-local model. In other
words, the overall model is produced by updating its weights
after averaging local update’s directions.
Fig. 7.3 shows benchmark results on resource usage in com-
parison between different runs. Fig. 7.3a shows how the du-
ration of each training epoch is higher for all the setups with
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Figure 7.3: Resources usage summary on different setups for
UniToPatho training.
the EDDL implementation. In this case we can not see a di-
rect link between the training time and the number of GPU in
EDDL runs.
While PyTorch implementation shows, for each setup, an
adaptive resources consumption, we can see a more constant
behaviour by using the European library. For example
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Fig. 7.3b shows how how the system memory requested by
PyTorch changes with the number of involved GPUs. Instead,
EDDL doesn’t not show similar memory usage cross different
setups. The same behaviour can be seen also in Fig 7.3c
and Fig 7.3e in GPU and CPU utilization respectively.
Furthermore we notice in Fig. 7.3c how the mean GPU
usage decreases if we enlarge the GPU pool for EDDL. This
behaviour can be brought back to what we said in Sec. 7.3:
EDDL is currently missing a dedicated dataset management
system, or data-loader, in order to supply the data efficiently
on each GPU. A less efficient data loading resolves to latency
and under usage of multiple GPUs capabilities. However
the development of EDDL is at its first release, so there are
incoming improvements and integration.
Inference Model [1] Time To Inference [s]
HP Adenoma Dysplasia Grade
EDDL/ECVL 3400 11.9 5330
PyTorch/OpenCV 1374 5.3 1381
Table 7.1: Timing differences in the UniToPatho inference
pipeline between both implementations. Adenoma classifica-
tion uses subsampled images at 224×224 pixels resolution
As a counter-evidence, the entire inference pipeline for the
UnitoPatho dataset was implemented in EDDL. Tab. shows
the execution times, by using a single GPU, for inference on
the test set of the dataset, including all the steps required to
process the 800×800µm images at full resolution. The imple-
mented pipeline uses the same pre-trained networks, in order
to measure the impact of using EDDL as inference engine and
ECVL as image processing engine. The results show that a gap
still exists, again due to EDDL’s lack of dataset management.
7.3.2 Evaluation on UniToBrain
We evaluate again the concurrent implementations on the same
HPC environment with four 16 GB GPUs NVIDIA Tesla T4.
Only comparisons for CBV perfusion synthesis are proposed
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below, as there are no notable variations in performances or
resource consumption compared with the other task targets,
TTP and CBF maps. As before, we setup the same envi-
ronment and the same experiment conditions to compare the
two libraries during distributed network training on dedicated
hardware. As previously, the setups are designed with 1, 2 or 4
dedicated GPUs. The refinement steps to 512×512 images, for
50 epochs, of the pre-trained model at 128×128 resolution are
considered. All simulations with EDDL were performed using
the ”full memory” option available on the neural model build-
ing phase. A 4 GPU run with “low memory” setup is shown as
a comparison. As before, we increase the batch size each time
we scale the number of GPUs, in order to fit the same number
of images processed on each GPU in each setup. Due to the
size of the inputs, 512×512×89 wide tensors, we use a batch
size equals to 1 for each GPU, and small learning rate of 1e−7.
Figure 7.4: Performance summary on UniToBrain use case. As
for UniToPatho, we maintain EDDL runs in purple to yellow
range color, while PyTorch runs in the blue to green range
color.
Fig. 7.4 shows the convergence to a solution is reached for
each training and for both libraries. The small differences in
the validation MSE metric is caused by the increments in the
batch size.
Fig. 7.5 propose the benchmark results also for UniTo-
Brain trainings across different implementation setups. Also
Fig. 7.5a shows how of each training epoch duration increases
in all the EDDL implementation setups. In this scenario, the
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Figure 7.5: Resources usage summary on different library and
environment setups.
gap between the execution time, across different implemen-
tations, is more evident: time decreases when the number of
GPUs is increased, but not enough to have a competitive com-
parisons with PyTorch-based solution. Again, the whole re-
sources consumption, shown by PyTorch implementation se-
tups, is adaptive on the number of available GPUs. The con-
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stant resource consuming behaviour by EDDL does not change.
As before, as we can see in Fig. 7.5c, the mean GPU usage de-
creases by increasing the dedicated hardware. This behaviour
support the previous consideration on the EDDL dataset man-
agement. Fig. 7.5e also shows, in terms of CPU usage, the
minor support to the data transfers when the training is deal-
ing with low batch sizes. We can see, as expected, the only
significant differences between EDDL “full” and “low” memory
setups in GPU memory allocation graph in in Fig. 7.5d.
In conclusion, EDDL is not yet at a sufficient stage of de-
velopment to replace, in terms of performance, solutions that
currently dominate the AI application development landscape.
Since the first release, EDDL already gives the possibility to
simplify the development of distributed training algorithms,
laying the foundations for a simplification in the use of hard-
ware acceleration components transparent to the developer.
With the addition of still missing components, such as an in-





We see how the entire landscape for biomedical research, and
healthcare in general, is growing in the direction of includ-
ing artificial intelligence applications in their processes chains.
The research in advanced clinical decision support have been
developed since the artificial intelligence concept began to find
its first application to solve real and complex problems. For
this reason, AI research finds an highly challenging application
field in medicine. We believe that the key role of AI integration
into the medical and diagnosis pipeline will be enhanced with
machine learning development of accurate medical predictions,
because healthcare needs to constantly improve the quality of
its provided care. We show how, in reality, healthcare con-
stitutes a particularly complex context for the application of
AI solutions, and each diagnosis support challenge, or task,
must be addressed starting from the assessment and analysis
of its related medical data. We explain how complex feature
extraction from medical data is, and how much this is related
to the collection and processing of the data itself. The re-
search results presented in this thesis have contributed to the
European Community efforts towards the development of a
common infrastructure to hold-up healthcare AI applications.
Such an effort consists in the presented DeepHealth project.
We see how the AI for medical application evolved through
time, from simplest rule-based prediction systems, defined by
medical expert users, to Deep Neural Networks applications,
based on automatic features extraction on the medical data.
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By using this paradigm, we see how different tasks can be ad-
dressed to solve real-world problems. One of the challenges
in training a deep neural network is to define a model with
high generalization results. Generalization improvements in
predictions are an active research area in training a neural
predictive model. We see how we can avoid a model to overfit,
and therefore retrain the whole dataset by including different
types of model regularizations. We also propose PSP as a
practical solution, and we see how such a technique can be ap-
plied also in the automatic treatment of medical tasks. We see
a practical use case in treating histopathological tissue analy-
sis by studying tissue fragments associated with a particular
disease. This thesis investigates colorectal polyps classifica-
tion in-depth, through applying Deep Learning techniques to
image processing. We see how in the medical image process-
ing field, the collected raw data, e.g. 2D scans like tissues
Hematoxylin & Eosin histology biopsies, presents dimensions
for each sample and high variance compared to their diagnosed
class of belonging. By focusing on colorectal polyps classifica-
tion case, the tissue scan data collection for the Deephealth
project continued beyond our publication of the first version
of the dataset UniToPatho. The collection is growing by in-
cluding new expert annotators for the biopsies samples. We
present an in-depth study on how the histopathologic tissues
samples collected within DeepHealth are suitable to investigate
and solve this task, by taking in consideration data unbal-
ancing treatment in tissue image preprocessing. We see how
to approach classification of UniToPatho images in multiple
ways, especially by developing a multi-resolution ensemble so-
lution of cascaded classifiers. This method helps us to reach
performance qualitatively comparable to the pathologist diag-
nosis. The study on image processing in the medical field was
enlarged by taking in consideration another use case, related
to brain image analysis. Specifically, we focus on collecting
and analyzing Computed Tomography scans of the brain, and
we use AI deep learning algorithms to identify cerebral ves-
sel occlusions in ischemic stroke cases. This study has been
included also as a use-case in DeepHealth project, by taking
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the name of UniToBrain. We show how is possible to reach
an Mean Square Error score below 0.01, that is a powerful in-
dicator on how the generated perfusion maps from CT scans
can be taken into account in order have an early and help-
ful instrument against ischemia stroke cases. The European
Union effort to maintain its proper position in this emergent
and challenging AI context is realized in the inclusion of our
use cases and their solution development by using a common
API interface, the DeepHealth Toolkit. By using this solution,
try to give you an overview of development paradigmas and
performance comparison on deep learning application devel-
opment paradigms between its EDDL/ECVL components and
the widely known and used PyTorch.
8.1 Future work
There are many directions in which the completed research
can be further explored and deepened. Regarding the au-
tomated analysis of histopathological tissues, some types of
polyps have been excluded from the collection, such as sessile
serrated polyp (SSA) and traditional serrated (TSA) due to
the impossibility of collection in a systematic way by the med-
ical institute. For this reason, it would be interesting to make
an analysis on the optimal resolutions to be taken into account
in order to make a more complete diagnosis. In addition, an
optimal method for inferring predictions from tissue clippings
to the whole biopsy result has not yet been defined, since in
the same biopsy there can be both areas of poor diagnostic in-
terest or multiple conformations of features for several types of
polyps, whose diagnosis has, however, different impacts on the
routine colonoscopic surveillance of patients. This part of the
research must be done in close contact with teams of expert
pathologists, since the sensitivity of the automatic diagnostic
tools must be such as to be a useful support in the diagnostic
pipeline in the field. In addition, AI models are sensitive to
the bias introduced by the scan acquisition tool. A lot could
be added to the research with the acquisition of biopsies with
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different tools, including various institutes, to verify the AI ap-
plications generalization, based on deep learning, on raw data
from different medical organizations. Regarding research on
the inference of cerebral perfusion maps for patients with is-
chemia strokes, there are many prospects for expansion. As
for all medical tasks in general, also in this case the AI models
are sensitive to the bias introduced by the image acquisition
tools, in this case CT scans. In perspective, it would be in-
teresting to investigate a solution based on data from multiple
institutions. Moreover, the performance obtained can inspire
to face other types of representations, or maps, even related
to different categories of brain classes, putting this as a tool
of prior prediction with respect to the following examinations
that the patient will have to face.
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